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MECHANISTIC INVESTIGATIONS OF PSEUDOURIDINE SYNTHASES—A 
SURPRISING GLYCAL INTERMEDIATE LIES ON THE REACTION PATHWAY 
 
Govardhan reddy Veerareddygari 
 
December 10, 2014 
 
 
Pseudouridine synthases (ΨSs) catalyze the isomerization of uridine (U) in 
RNA to pseudouridine (Ψ), which is the most common post-transcriptional 
modification in RNAs and is ubiquitous within all three domains of life. ΨSs are 
classified into six different families based on sequence alignments and have a 
universally conserved aspartic acid residue (‘conserved Asp’ for simplicity) that is 
absolutely essential for activity. RNA containing 5-fluorouridine ([F5U]RNA) has 
been used as a mechanistic probe. Upon incubation with [F5U]RNA, TruA and 
RluA get irreversibly inhibited and appear in a protein-RNA adduct band on 
denaturing PAGE gels, which is consistent with the ‘Michael mechanism’ that 
proposes a covalent adduct between the conserved Asp and the pyrimidine ring. 
E. coli TruB does not get inhibited upon incubation with [F5U]RNA, nor does it form 
an adduct and instead converts F5U into two rearranged, hydrated products. 18O 
labeling studies with the E. coli ΨSs TruA, TruB, RluA, and TruD show that the 
vii 
 
hydration of the products of F5U occurs directly from solution and not through the 
hydrolysis of a Michael adduct. These 18O labeling studies were extended here to 
Thermotoga maritima TruB (TmTruB) which showed a behavior intermediate 
between that of E. coli TruB (no observed adduct; multiple turnovers) and RluA 
and TruA (stoichiometric adduction; single turnover). 18O label is incorporated into 
RNA directly from solvent during the reaction of [F5U]RNA catalyzed by TmTruB. 
These results are consistent with the scheme proposed earlier for the handling of 
F5U by ΨSs. Among examined ΨSs, TmTruB uniquely shows the interesting ability 
to catalyze the dehydration and rehydration of the products of F5U. 
The minor product of F5U from the action of ΨSs is an arabino isomer and 
its generation requires epimerization at C2′, which suggested that the ΨS 
mechanism may proceed by deprotonation of C2′ to eliminate the uracil and form 
a glycal intermediate. To test this mechanistic possibility, substrate RNA stem-
loops containing [2′-2H]uridine were prepared and used to measure the deuterium 
kinetic isotope effect on the conversion of U to Ψ. Deuteration at C2′ reduced both 
Vmax and Vmax/Km for the reaction as catalyzed by TruB (2.54-fold and 3.58-fold, 
respectively) and RluA (1.79-fold and 2.17-fold, respectively). These results 
conclusively indicate that the deprotonation of C2′ occurs in a partially rate-
determining step in the conversion of U to Ψ, which is consistent with the ‘glycal 
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PSEUDOURIDINE AND THE PSEUDOURIDINE SYNTHASES 
Pseudouridine (Ψ), the C-glycoside isomer of uridine (U) is a ubiquitous 
constituent of structural RNAs, and it is the most common post-transcriptional 
modification in all three domains of life (Figure 1.1). The enzymes that catalyze 
this isomerization of U to Ψ are the pseudouridine synthases (Ψ synthases), and 
they use both sequence and structural information to achieve site-specific 
generation of Ψ in particular RNA contexts. [1] 
Pseudouridine and its physiological significance 
The existence of Ψ in yeast tRNA was reported in 1957, [2] and Ψ was 
subsequently found in all non-coding RNAs. [2] In 1970, Johnson and Söll reported 
site-specific Ψ synthase activity in Escherichia coli extracts. [3] Most recently, 
Carlile and co-workers reported Ψ in mRNAs and showed that its occurrence is 
heavily regulated. [4] Pseudouridine is physically and chemically distinct from its 
parent uridine. The C-C glycosidic bond in Ψ exhibits enhanced rotational freedom 
as compared to the C-N glycosidic bond in U. [5] CD spectroscopy [6], nuclear 
magnetic resonance (NMR) studies, [6] and molecular dynamic simulations [7] all 
suggest that Ψ imparts structural rigidity in both single- and double-stranded 
RNAs, possibly due to the free imino proton in Ψ that can act as an additional 













Figure 1.1: The isomerization of U to Ψ 
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in polynucleotide chains provides an appropriate geometry for coordination of a 
water molecule between the imino proton and the 5′-phosphate backbone of its 
preceding residue, thereby restricting the base conformation and mobility of the 
backbone. [8] Additionally, Ψ enhances local RNA stacking, which is perhaps the 
most important contribution of Ψ towards stabilizing the RNA structure. [8] 
The ubiquity of Ψ across all forms of RNA emphasizes its physiological 
importance. Lack of Ψ at positions 1911, 1915, and 1917 of 23S rRNA in E. coli 
causes severe growth retardation. [9-11] In Thermus thermophilus, Ψ55 in tRNA 
is essential for the low temperature adaptation of this extremophile. [12] Depletion 
of the Ψ synthase encoded by minifly in Drosophila results in a severe reduction 
in the wing size by decreasing both the number and size of wing cells (due to cell 
death rather than reduced cell proliferation). [13] Mutations in the human gene 
dyskerin, an ortholog of the Ψ synthase-encoding Cbf5 gene is shown to be 
associated with the X-linked form of dyskeratosis congenita, a rare hematopoietic 
and malignant disorder. [14-16] Individuals with this disorder show increased 
cancer susceptibility, failure in ribosome biogenesis, and cells with decreased 
telomerase activity that results in a difficulty maintaining the telomere length. [14-
16] In humans, a single mutation in the PUS1 gene has been correlated with 
mitochondrial myopathy and sideroblastic anemia. [17] The tRNAs of patients with 
this affliction lack the Ψ expected to be generated by Pus1p. [17] 
Pseudouridine synthases 
Based on sequence comparisons and structural analysis, six different 
families of Ψ have been classified: TruA, TruB, RluA, RsuA, TruD and PUS10, 
4 
 
which are named after the first cloned member of the family. [18, 19] Despite the 
lack of statistically significant global sequence similarity, a superimposition of the 
crystal structures of Ψ synthases reveals a conserved core β-domain, strongly 
suggestive of divergent evolution. [20] Biochemical characterization revealed that 
Ψ synthases do not require any cofactors for catalysis, nor do they release 
detectable amounts of uracil during the isomerization of U to Ψ. [21-23] The Ψ 
synthases share several amino acids conserved across all the families in both 
sequence and structure. The active site cleft of all six families shows an absolutely 
conserved aspartic acid residue (hereafter, the ‘conserved Asp’), a conserved 
basic residue (Arg or Lys), and two aromatic residues (Phe or Tyr). Site-directed 
mutagenesis in a multitude of Ψ synthases revealed the conserved Asp to be 
essential for enzyme activity. [9, 10, 24-27] In cocrystal structures of several Ψ 
synthases with RNA, the conserved Asp lies in close proximity to the isomerized 
nucleotide, which supports direct participation in catalysis. [20]  
Ψ synthases recognize their substrate uridine in the context of an RNA, 
isomerizing certain positions in particular RNA (Figure 1.2) Except for Cbf5p and 
its orthologs, which function as a part of an elaborate ribonucleoprotein complex, 
all other Ψ synthases characterized to date recognize their substrates without 
relying on accessory factors. [20]  
Most of the mechanistic work reported in this dissertation is with the TruB 
family. TruB is responsible for the pseudouridylation of U55 in the T-arm stem loop 
(TSL) of all non-initiator tRNAs. [28] While some Ψ synthases can only handle full 
length tRNA as a substrate, E. coli TruB and RluA handle small stem-loop 
5 
 
substrates as well as the full-length tRNA. [29, 30] Santi and co-workers reported 
that the kcat and Km values for TruB and a 17-mer RNA oligonucleotide 
corresponding to the TSL of Saccharomyces cerevisiae tRNAPhe were identical 
within error of the values with full-length tRNA. [29] Similar results were obtained 
by a predecessor in the Mueller group for RluA in a comparison of full-length           
E. coli tRNAPhe and the 17-mer corresponding to its anticodon stem-loop (ASL). 
[30] 
 
Proposed mechanisms for Ψ synthases 
5-fluorouridine  
Previous mechanistic work with Ψ synthases relied on site-directed mutagenesis 
and RNA containing 5-fluorouridine ([F5U]RNA) in the place of U (Figure 1.3). 5-
Fluorouracil is a potent anti-cancer drug especially useful in treating colorectal 
cancer. [31] Early work by Frendewey et al. demonstrated the potent inhibitory 
action of tRNAs containing F5U on unfractionated tRNA Ψ synthases. [32] In their 
work on thymidylate synthase, Santi and co-workers demonstrated that F5U gets 
converted into several intracellular active metabolites such as 5-fluorodeoxyuridine 
monophosphate (F5dUMP), which acts as an inhibitor of thymidylate synthase, the 
sole de novo source of thymidylate for DNA replication and repair. [31, 33, 34] 
They further showed that thymidylate synthase irreversibly forms a Michael adduct 
between the thiol group of an active site cysteine residue and C6 of F5dUMP, 





Figure 1.2: The classic ‘cloverleaf’ representation of E. coli tRNAPhe. The T-
arm stem loop is the truncated substrate for TruB, which isomerizes U55.  
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Inspired by this precedent, Penhoet and co-workers proposed a mechanism 
for Ψ synthases in their report of the characterization of TruA. [35] They proposed 
a nucleophilic attack by an unidentified enzymic cysteine residue at C6 of U to form 
a dihydropyrimidine-enzyme adduct. Such an adduct was purported to 1) enhance 
the lability of N-glycosidic bond, 2) provide an axis for the 180° rotation of the 
pyrimidine ring to reposition C5 for C-glycosidic bond formation, and 3) activate 
the proton on C5 of rearranged pyrimidine ring for subsequent β-elimination to give 
the product. [35] This proposed mechanism seemed to be supported by the 
observed inhibition of TruA upon incubation with sulfhydryl reagents.[35] To test 
this mechanistic premise, Santi and co-workers probed for the formation of 
covalent adduct for TruA by incubating it with full length [F5U]tRNA transcripts. [29] 
SDS-PAGE and urea-PAGE analysis of the reaction mixture showed a slower 
moving protein-RNA adduct band on both gels. This putative covalent adduct band 
disappeared when the sample was heated, and mass spectrometric analysis of the 
RNA from heat-denatured adduct revealed that F5U in the RNA was hydrated [36] 
However, when one or all of the three cysteines in TruA were mutated, only a very 
modest decrease in the activity of TruA was observed. [37] Sequence alignments 
subsequently revealed that no cysteine residues were conserved and instead 
identified the conserved Asp, which became the candidate nucleophile. [29] These 
observations led Santi and co-workers to the reasonable conclusion that TruA 
proceeds through a mechanism (the ‘Michael mechanism’, Figure 1.4) analogous 
to that of thymidylate synthase and other methyl transferases with the exception 
that the conserved Asp acts as the nucleophile. [36]  
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However, because of the lack of biochemical precedence for Asp acting as 
a Michael nucleophile, Santi and co-workers also proposed an alternative 
mechanistic scenario (‘acylal mechanism’, Figure 1.6) in which the conserved Asp 
nucleophilic attacks at C1′ of U to form an acylal intermediate [36, 38] This scenario 
is well-precedented in retaining glycosidases. [39] The detached pyrimidine ring 
then rotates to reposition itself for the formation of bond between C5 and C1′, and 
subsequent deprotonation of the C5 generates Ψ. However, because radiolabeling 
studies indicated that the pyrimidine ring of F5U was attached to the enzyme, Santi 
and co-workers favored the Michael mechanism over the acylal mechanism. [36]  
Cocrystal structure of TruB with [F5U]TSL 
Based on the presumption that TruB also follows the Michael mechanism 
and would be inhibited by [F5U]RNA, Hoang and Ferré-D’Amaré cocrystallized 
TruB with [F5U]TSL, and they fully expected to see a covalent linkage between the 
enzyme and the RNA. However, a noncovalent complex was observed in which 
the hydrated F5U was rearranged to the C-glycoside isomer (Figure 1.5). [40] 
These observations led Hoang and Ferré-D’Amaré to conclude that TruB follows 
the Michael mechanism, but the reaction proceeds to the C-glycoside isomer. The 
failure to observe a covalent adduct in the cocrystal was ascribed to the slow ester 
hydrolysis of the rearranged Michael adduct that occurred over the course of 
crystal growth and diffraction analysis. [40] 
Subsequent biochemical investigations by Spedaliere and Mueller, 
however, proved definitively that TruB neither gets inhibited by nor forms a stable 




Figure 1.3: A, 5-fluorouridine. B, The Michael adduct between TruA and 




Figure 1.4: The proposed ‘Michael mechanism’ for Ψ synthases. The 
conserved Asp makes a nucleophilic attack on C6 of the pyrimidine ring to 
form a Michael adduct. N-glycosidic bond cleavage then occurs, and the 
pyrimidine ring makes a net 180° rotation to reposition itself for the 
subsequent C-glycosidic bond formation. Cleavage of the rearranged adduct 









Figure 1.5: A, The hydrated product proposed by Santi and co-workers, cis-
(5S,6R)-6-hydroxy, 5, 6-dihydro-5-fluorouridine. [29] B, The hydrated 
rearranged product of F5U (cis-(5S,6R)-5-fluoro, 6-hydroxypseudouridine) 
observed by Hoang and Ferré D’Amaré in the cocrystal structure of TruB 








Figure 1.6: The ‘acylal mechanism’ for Ψ formation, which begins with the 
conserved Asp making a nucleophilic attack on C1′ of the ribose ring either 
through a concerted or step-wise process, thereby displacing the pyrimidine 
ring. After N-glycosidic bond breakage, the uracilate anion makes a 180° 







hydrated C-glycoside isomer (F5U*) in a time frame similar to the conversion of U 
to Ψ. Furthermore, HPLC analysis of the nucleotides resulting from treatment of 
the product RNA with S1 nuclease and alkaline phosphatase showed two more 
polar products of F5U, which were shown to be hydrated by mass spectrometry. 
[25] Subsequent NMR experiments by Miracco and Mueller established that both 
F5U products were rearranged similarly to the one seen in the cocrystal structure 
of TruB with [F5U]RNA. [41] 
18O labeling studies 
To elucidate the mechanism of the Ψ synthases further, Spedaliere and 
Mueller conducted labeling experiments with TruB and [F5U]TSL in [18O]water. [42] 
If the mechanism were to proceed through the formation of a Michael adduct and 
heating the adduct did indeed lead to the proposed ester hydrolysis, then running 
the reaction in [18O]water would result in the incorporation of 18O label into the 
conserved Asp (Figure 1.7). Instead, the label ended in RNA, ruling out ester 
hydrolysis. [42] The same result held for RluA and TruA. [30, 41] These 
observations led Mueller and co-workers to propose a scheme to account for the 
handling of F5U by all Ψ synthases (Figure 1.8). The Ψ synthase reaction proceeds 
through either the Michael or acylal to rearranged F5U, and idiosyncracies of the 
active site dictate its fate. In some active sites (TruA and RluA, for example), the 
conserved Asp can reach C6 and make a stable adduct whether it had previously 
been formed (Michael mechanism) or not (acylal mechanism). In this case, the 
stable covalent adduct between the conserved Asp and [F5U]RNA undergoes 
elimination (rather than ester hydrolysis) upon heating, followed by spontaneous 
14 
 
hydration of the rearranged F5U in solution. [30, 41] In other active sites (TruB, for 
example), the conserved Asp does not form a stable adduct with the pyrimidine, 
so the rearranged F5U is simply released into solution followed by hydration. 
Identity of the products of F5U 
The definitive structural elucidation of the two F5U products of TruB was 
undertaken to provide further mechanistic insight. After isolating the F5U* from the 
action of both TruB and RluA on a suitably large scale, Miracco and Mueller used 
a myriad of NMR experiments to establish the identity of the products. [43] Their 
NMR studies revealed that both of the isolated products were dinucleotides (Figure 
1.9), [41] which explained an apparent discrepancy in the HPLC behavior for the 
F5U products formed by the reaction of TruB and RluA. [41] The products from the 
action of TruB had different retention times than the single peak resulting from the 
action of RluA. Since the RNA substrates differ in the nucleoside following the 
isomerized U, the different retention times were immediately explained. The single 
peak for the products of F5U from RluA action were simply not resolved by the 
HPLC conditions. The maintenance of an approximately 3:1 ratio of the two 
products of F5U through the process of enzymatic digestion, isolation, and storage 
strongly suggested that the two products differed by stereochemical rather than 








Figure 1.7: 18O labeling scheme. A, Ester hydrolysis would result in 18O 
incorporation into the conserved Asp. B, Direct hydration of the 






Figure 1.8: The proposed consistent scheme for the handling of F5U in 
RNA by different Ψ synthases. [41]  
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The major product was confirmed as the one seen in the cocrystal structure 
of TruB with [F5U]TSL. [40, 43] The minor product proved even more interesting. 
First, when comparing the chemical shifts of sugar protons in the two products, H2' 
and C2′ of the minor product were deshielded, an indication that the minor product 
differs from major product at C2′ of ribose rather than C6 of the pyrimidine ring. 
[43] Second, 1H-1H Nuclear Overhauser Effect experiments (NOE) showed a 
strong correlation between H2′ and H5′/H5′′ for the major product that was absent in 
the minor product, a result which indicated greater separation between H2′ and 
H5′/H5′′ in the minor product. [43] Third, the strong NOE seen between F5 and H2′ 
in the major product was absent in the minor product, and the minor product also 
lacked a detectable NOE between H2′and H6 for minor product that was observed 
in the major product. [43] These findings along with residual dipolar coupling 
experiments and density functional theory calculations established the identity of 
the minor product to be the arabino isomer whereas the major product was the ribo 
isomer. These two products, then, differ in stereochemistry at C2′ (Figure 1.9). For 
the arabino product to form, epimerization at C2′ must occur, which requires 
deprotonation of C2′ to form a glycal intermediate followed by reprotonation of C2′ 





Figure 1.9: The major and minor products of F5U*differ in stereo 




Figure 1.10: The “glycal mechanism” for Ψ formation. The conserved Asp 
initiates the reaction by deprotonating C2′ which leads to a glycal 
intermediate. After the C-glycoside rearrangement, C2′ is reprotonated by 




Figure 1.11: The “glycal mechanism” with F5U. Reprotonation from the 







Implications of a glycal intermediate  
If a glycal intermediate exists along the reaction pathway, a new 
mechanistic possibility emerges, the ‘glycal’ mechanism. (Figure 1.10) Uridine 
phosphorylase offers a biochemical precedent for glycal intermediate formation in 
enzymes. [44] Deprotonation of the C2′, followed by reprotonation from the 
“bottom” face would explain the observed arabino F5U product (Figure 1.11).The 
acylal mechanism can also account for the formation of an arabino product of F5U. 
The decreased nucleophilicity of the 5-fluorouracilate anion effectively increases 
the lifetime of the acylal intermediate, which is in equilibrium with the oxocarbenium 
species and the free conserved Asp. The increase in acidity of C2′ in the 
oxocarbenium species facilitates its deprotonation by the conserved Asp to give 
the glycal intermediate. In such case, reprotonation of the glycal intermediate from 
the “bottom” face results in an arabino product (Figure 1.12). [43]  
Because the conserved Asp is the only acidic group in proximity to the sugar 
ring to effect reprotonation of C2′ from the “bottom”, the arabino product strongly 
disfavors the Michael mechanism, for the conserved Asp is tied up in an ester bond 
at the critical time. The alternative protonation directly by solvent (specific rather 
than general acid catalysis) was ruled out by running the Ψ synthase reaction with 
[F5U]RNA in buffer made with deuterated water1. [45] However, prior to the findings 
by Miracco and Mueller that led to the proposal of glycal mechanism, the glycal 
mechanism was still favored by many. To probe whether the Michael mechanism   
                                                
1 This result also rules out exchange of the proton on the enzymic general acid with 




Figure 1.12: The acylal mechanism recast to emphasize features that can 
account for the arabino product of F5U. The boxed manifold exists only 
for F5U because of the increased life time of the oxocarbenium ion that is 
in equilibrium with the acylal intermediate. [43] 
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in some form can still accommodate the glycal intermediate, additional mechanistic 
possibilities were considered. Such considerations in the context of recently 
published results [46] are presented in the next few sections of this chapter. 
Cocrystal structure of RluB with [F5U]RNA 
While the existence of arabino product of F5U strongly argues against the 
Michael mechanism, others continue to champion it. Among them are Stroud and 
co-workers, who recently reported a cocrystal structure of RluB with [F5U]RNA that 
shows a covalent linkage between C6 of the pyrimidine ring and Tyr-140 (Figure 
1.13). [46] Although a covalent adduct with Tyr does not provide direct evidence 
for the formation of a Michael adduct by the conserved Asp, Stroud and co-workers 
proposed a ‘modified’ Michael mechanism (Figure 1.14) that is essentially the 
‘consistent scheme’ (Figure 1.15) grafted on to the Michael mechanism. The 
conserved Asp forms a Michael adduct, followed by rearrangement of U to the      
C-glycoside isomer. The conserved Asp then undergoes elimination to yield the 
reactive intermediate, which in case of [F5U]RNA either gets hydrated (in the 
cocrystals of TruB and RluA with [F5U]RNA) or forms a covalent adduct with Tyr-
140 (in the case of RluB). (Figure 1.13)  
The mechanism proposed by Stroud and co-workers is based on the 
assumption that the conserved Asp initially forms a covalent adduct with the 
pyrimidine ring of [F5U]RNA. [46] However, no evidence directly identifies the 
conserved Asp as the nucleophile that forms the Michael adduct. Although 
substitution of the conserved Asp abrogates adduct formation, it may be required 









Figure 1.13: A close up view of the active site from the cocrystal structure 
of RluB and [F5U]RNA reported by Stroud and co-workers. A covalent 
linkage can be seen between the Tyr-140 and C6 of the pyrimidine ring of 




Figure 1.14: The modified Michael mechanism proposed by Stroud and 
co-workers. The conserved Asp initially forms a covalent adduct with the 
C6 of the pyrimidine ring. After rearrangement to the C-glycoside, the 
conserved Asp undergoes elimination. In the case of [F5U]RNA, the F5U 
gets hydrated in solution or, in the case of RluB, forms a covalent adduct 
with Tyr-140. [46] 
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adduct. The modified Michael mechanism also fails to explain the observed 
arabino product of F5U, which requires epimerization at the C2′ of the ribose ring. 
[43]  
The consistent scheme proposed by the Mueller group, on the other hand, 
still accounts for all observations (Figure 1.15). The Ψ synthases proceed through 
either the glycal mechanism or the acylal mechanism (re-cast in the wake of 
arabino product) to rearranged F5U. In the case of RluB, instead of release into 
solution and spontaneous hydration, the phenolic –OH of Tyr-140 attacks at C6 of 
the pyrimidine ring to form the observed covalent adduct, which occurs because 
the idiosyncracies of the RluB active site allow formation of a stable adduct with 
Tyr-140. This scenario is supported by the results with Thermotoga maritima TruB. 
The interesting case of Thermotoga maritima TruB (TmTruB) 
In an attempt to obtain a covalent adduct of TruB, Huang and co-workers 
incubated TruB from four different organisms with [F5U]RNA, and T. maritima TruB 
(TmTruB) formed a covalent adduct as judged by the appearance of a shifted band 
on an SDS-PAGE gel (Figure 1.16); heat treatment disrupted the adduct. [47] No 
such adducts were seen with TruB from E. coli (EcTruB), B. subtilis, or S. 
cerevisiae. [47] However, the cocrystal structure of TmTruB with [F5U]TSL, 
showed a noncovalent adduct identical to the one seen in case of EcTruB with 
[F5U]TSL. [40, 47] This seemingly disparate behavior made TmTruB an intriguing 
candidate for further characterization. These studies are described in Chapter 2 of 










Figure 1.15: The consistent scheme proposed by Mueller and co-workers 
with mild revision to account for the arabino product of F5U and trapping by 
Tyr-140 of RluB. 
28 
 
The possibility of an active site Tyr forming the Michael adduct 
One other scenario that could accommodate a catalytic Michael adduct and 
the epimerization at C2′ would be another nucleophile to form the initial Michael 
adduct which would leave the conserved Asp free for the 
deprotonation/reprotonation of C2′. The Ψ synthases show a conserved aromatic 
amino acid residue, which is a Tyr in five of the six families (it is the tyrosine seen 
in adduction with [F5U]RNA in the RluB cocrystal). However, several lines of 
evidence argues against the role of Tyr forming a Michael adduct. The fully 
functional TruD family has nucleophilically incapable Phe residues in this 
conserved position. [48-50] Additionally, Huang and co-workers have reported that 
Y76F, Y76L, and Y76A TruB were inactive towards the natural substrate (with U) 
but do handle [F5U]RNA to generate rearranged, hydrated products of F5U. [51] If 
the mechanism proceeds by the forming an initial Michael adduct between Tyr and 
the pyrimidine ring, the Tyr variants should have left both U and F5U unchanged 
(if the adduct does not form, rearrangement to the C-glycoside should not occur). 
Finally, the pH profile studies on TruB by Mueller and co-workers suggest that the 
active site tyrosine residue functions in its protonated form to assist N-glycosidic 
bond cleavage of the uridine, presumably by donating either a proton or hydrogen 
bond to the pyrimidine ring. [26, 52] In either scenario for the active site tyrosine 
residue, the N-glycosidic bond cleavage of F5U does not require the assistance of 
Tyr because the inductive effect of fluorine makes its anion a better leaving group 
than the anion of uracil. 
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An arabino product of F5U must arise from epimerization at C2′ after its 
deprotonation. To probe whether the C2′ is deprotonated during the course of the 
reaction with natural substrate and thus test the operation of the glycal mechanism, 
stem-loop substrates labeled with deuterium at the C2′ position of U were prepared 
and their rate of reaction compared to those of unlabeled substrates. If the glycal 
mechanism operates and either deprotonation or reprotonation of C2′ is at least 
partially rate-limiting, replacement of proton on C2′ with deuterium should result in 
a primary kinetic isotope effect and provide definitive evidence for glycal formation. 







Figure 1.16: A, The interaction of TmTruB and [F5U]RNA. [51] An adduct band 
(indicated by the arrow) was observed when Huang and co-workers 
incubated TmTruB with [F5U]TSL. The increased electrophoretic mobility 
was attributed to a more compact confirmation that resisted denaturation 
under the SDS-PAGE conditions. B, A superimposition of the cocrystals of 
TmTruB and EcTruB with [F5U]RNA show the same product of F5U and nearly 










MECHANISTIC INVESTIGATIONS OF THERMOTOGA MARITIMA 
TruB 
 
Pseudouridine synthase TruB 
The pseudouridine synthases (Ψ synthases) isomerize uridine (U) to its      
C-glycoside isomer pseudouridine (Ψ), which is the most common modified 
nucleoside in RNA. [1] Ψ synthases are classified into six families that share no 
statistically significant global sequence similarity. [18, 53] The pseudouridine 
synthase TruB isomerizes the universally conserved U55 in the T-arm of tRNA, 
[28] and homologs of TruB have been found in all organisms. [54-58] Deletion of 
the E. coli TruB (EcTruB) gene does not cause a detectable growth defect. 
However, truB mutants exhibit a competitive disadvantage in extended co-culture 
with wild-type E. coli and a survival defect upon rapid transfer from 37 °C to 50 °C. 
[59] Deletion of TruB in Shigella flexneri reduces the expression of some virulence-
associated genes, and disruption of TruB by Tn5 in Pseudomonas aeruginosa 
causes impaired growth and reduced virulence. [60, 61] TruB-catalyzed Ψ55 
modification in Thermus thermophilus is essential for the low temperature 
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adaptation of this extremophile. [12] The ubiquity of truB across all eubacteria 
implies the presence of both TruB and Ψ55 modification in the common ancestor 
of eubacteria. [62] Though several homologs of TruB have been studied, crystal 
structures are available only for EcTruB and Thermotoga maritima TruB (TmTruB). 
[40, 47] TmTruB efficiently handles 17-mer stem-loop substrates corresponding to 
the T-arm stem loop (TSL) of tRNA. [29, 47, 63] EcTruB is not inhibited upon 
incubation with RNA containing 5-fluorouridine ([F5U]RNA) whereas TruA and 
RluA appear to form a covalent adduct with [F5U]RNA and thus become irreversibly 
inhibited. [30, 36, 42] Three mechanisms have been proposed (Chapter 1), and 
they all involve an active site aspartic acid residue (hereafter, the ‘conserved Asp’) 
that is essential for Ψ synthase activity in all tested cases, which span all six 
families. [36, 43, 64, 65] The first of these proposed mechanisms—the “Michael 
mechanism”—involves the conserved Asp nucleophilically attacking the pyrimidine 
ring at C6 to form a Michael adduct (Figure 1.4). [36]  
When TruA is incubated with [F5U]RNA, a slower moving adduct band 
appears on SDS-PAGE gels; this adduct band collapses to separate protein and 
RNA bands when the sample is heated prior to loading. [36] Furthermore, mass 
spectrometric analysis revealed that F5U in the RNA is hydrated after the adduct 
is heat-disrupted. These observations led Santi and co-workers to conclude that 
the conserved Asp of TruA formed a Michael adduct with [F5U]RNA, and heat 
treatment of this adduct led to hydrolysis of the adduct ester bond to leave the F5U 
hydrated (Figure 2.1). When Hoang and Ferré-D'Amaré later obtained a cocrystal 
structure of TruB with [F5U]TSL, they observed not a covalent adduct but a 
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rearranged hydrated product of F5U. This unexpected observation led them to 
conclude that TruB followed the Michael mechanism through the rearrangement 
step, at which point reaction stopped. The failure to observe the covalent adduct 
was ascribed to slow ester hydrolysis over the course of crystal growth and 
diffraction analysis. [40]  
Phannachet and Huang attempted to trap a covalent adduct between TruB 
and [F5U]TSL. They incubated TruB from four different organisms (E. coli, Bacillus 
subtilis, T. maritima, and Saccharomyces cerevisiae) with [F5U]TSL, and 
denaturing PAGE gel analysis revealed that only TmTruB formed an apparently 
covalent adduct (Figure 1.7). [47] With TmTruB alone, a new band was observed 
with greater electrophoretic mobility than the protein alone, and the extracted band 
showed a maximum absorbance at 260 nm, indicating the presence of RNA 
(nucleic acids show a characteristic absorption maxima at ~260 nm). [47] The 
TmTruB-RNA adduct was also heat labile. Huang and co-workers grew cocrystals 
of TmTruB with [F5U]TSL and expected to observe a covalent adduct. Despite 
short crystallization times and low incubation temperatures (48 h at 4 °C), the 
cocrystal structure of TmTruB with [F5U]RNA was identical to that of EcTruB, with 
no evidence of a covalent linkage between the protein and [F5U]RNA and the same 
rearranged, hydrated product seen in the co-crystal of EcTruB and [F5U]RNA 
(Figure 2.2). [47]. Moreover, the RNA-protein complex recovered from the crystals 
showed similar gel behavior to that of the purified complex prior to crystallization. 
[47] Because of their failure to trap a covalent adduct, the Huang group did not 
speculate as to which mechanistic pathway the Ψ synthases follow. 
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Spedaliere and Mueller concurrently found that EcTruB is not inhibited by 
[F5U]TSL, instead converting F5U into a pair of hydrated C-glycoside isomers 
(F5U*) in a time frame similar to the conversion of U to Ψ. [25] Subsequent NMR 
experiments reported by Mueller and co-workers confirmed that both F5U products 
were rearranged similarly to the one seen in the cocrystal structure of TruB with 
[F5U]RNA. [41] Spedaliere and Mueller also conducted 18O labeling studies with 
EcTruB to probe the putative ester hydrolysis of the Michael adduct. [42] If the 
mechanism indeed proceeded through a Michael adduct followed by 
rearrangement and a relatively fast ester hydrolysis step, running the reaction in 
[18O]water would result in the incorporation of 18O into the conserved Asp (Figure 
2.3). Mass spectroscopic analysis of the tryptic digestion products of TruB after 
incubation with [F5U]TSL revealed no 18O incorporation into the conserved Asp but 
instead showed label directly incorporated into F5U*. [42] These studies were later 
extended to the E. coli Ψ synthases RluA, TruA, and TruD, all of which showed the 
incorporation of 18O directly into RNA rather than the conserved Asp. [30, 42, 66, 
67] These results led to the proposal of a scheme for the hydration step consistent 
with all observations (Figure 2.4). [42] The F5U is rearranged by either mechanism, 
and then idiosyncrasies in the active site geometry dictate the fate of the initial 
product. In the case of TruA and RluA, the conserved Asp can form a stable 
covalent adduct with C6 of the pyrimidine ring, and upon heating, it undergoes 
elimination followed by spontaneous hydration of the rearranged F5U in solution. 
With TruB, the conserved Asp cannot form a stable adduct, so the rearranged F5U 
















Figure 2.1: The Michael adduct proposed by Santi and co-workers 
between the conserved Asp and C6 of the pyrimidine ring. Heat 






Figure 2.2: An overlay of the cocrystal structures of EcTruB and TmTruB 
with [F5U]RNA and the line drawing of the rearranged, hydrated product 





Figure 2.3: Scheme for the 18O labeling studies. A, Ester hydrolysis would 
result in the incorporation of 18O into the conserved Asp. B, Direct hydration 





Figure 2.4: Scheme accounting for the formation of apparently covalent 
adducts by TruA and RluA but not TruB and for the generation of two 
hydrated products by all three Ψ synthases. [66]  
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This chapter describes investigation into the behavior of TmTruB towards 
[F5U]RNA. They were undertaken to resolve apparent discrepancies from gel 
analysis (a covalent adduct appears to form) and X-ray crystallography (no adduct 
is observed). The results were expected to illuminate the mechanism and also 
resolve some questions raised by the partial characterization of TmTruB reported 
by Phannachet and Huang. [47] First, do TmTruB and EcTruB show similar 
kinetics, and if not, how do they differ? Second, although TmTruB forms an adduct 
with [F5U]TSL as judged by SDS-PAGE analysis, the nature of this adduct as 
covalent or very tight but noncovalent remained uncertain. Third, if the adduct is 
covalent, is it the proposed Michael adduct between the C6 of the pyrimidine ring 








All chemicals, unless specified were purchased from Fisher Scientific 
(Pittsburgh, PA) or Sigma-Aldrich (Milwaukee, WI). BLR(DE3) pLysS cells were 
purchased from Novagen (Madison, WI). A DNAPac® PA200 column (4  250 mm) 
was purchased from Dionex (Sunnyvale, CA). A CLIPEUS C8 5-µm column (250  
4.6 mm) was purchased from Higgins Analytical, Inc. (Mountain View, CA), and a 
Zorbax analytical SB-C18 5-µm column (50  4.6 mm) was purchased from Agilent 
(Santa Clara, CA). A HiPrep 16/60 Sephacryl S-200 HR size exclusion column and 
Sephadex G-25 resin were purchased from GE Healthcare (Pittsburgh, PA). Ni-
NTA superflow resin and QIAprep Spin Mini prep kits were purchased from Qiagen 
(Chatsworth, CA). S1 nuclease and calf intestinal alkaline phosphatase were 
purchased from Promega (Madison, WI). Modified trypsin (sequencing grade), 
endoproteinase Glu-C (sequencing grade), and RNase T1 were purchased from 
Roche (Indianapolis, IN). QuickChange site-directed mutagenesis kits were 
purchased from Stratagene (La Jolla, CA). [18O]water (99.7%, v/v) was purchased 
from Sigma-Aldrich (Milwaukee, WI). Ultra-pure deionized water was obtained 
using a Millipore® Milli-Q integral system (Billerica, MA) equipped with a 0.2 µm 
filter. Laemmli buffer (2x) was 120 mM Tris•HCl buffer, pH 6.8, containing SDS 
(4%, w/v), glycerol (20%, v/v), and bromophenol blue (0.02%, w/v). RNA loading 
dye (2x) was 95% aqueous formamide, containing bromophenol blue (0.025%, 
w/v), xylene cyanol (0.025%, w/v), and EDTA (0.5 mM). 
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Subcloning, overexpression, and purification of wild-type and D39A TmTruB  
The recombinant plasmid for TmTruB (pUL390) was prepared by ligating          
T. maritima truB into the expression vector pET-15b (Novagen) so that an                
N-terminal His6•tag was fused to expressed TmTruB. The plasmid encoding D39A 
TmTruB (pUL391) was created by introducing a point mutation into truB in pUL390 
using the Stratagene QuickChange site-directed mutagenesis kit according to 
the manufacturer’s protocols and with the following primers: 
GGACACGGAGGAACTCTCGCCCCGTTCGCCTGTGGG (forward), and 
CCCACAGGCGAACGGGGCGAGAGTTCCTCCGTGTCC (reverse). The inserts 
in both plasmids (pUL390, pUL391) were verified by DNA sequencing.             
BLR(DE3) pLysS cells were transformed with pUL390 and pUL391 for the 
overexpression of wild-type and D39A TmTruB, respectively. Both were purified 
over Ni-NTA resin using the same protocol used for EcTruB. [64] TmTruB was 
further purified over a POROS HQ anion exchange column (PE Biosystems) 
attached to a BioCAD SPRINT FPLC run by Perfusion Chromatography 
Workstation v3.01. Elution was achieved by the application of a gradient of sodium 
chloride (0–1.0 M) in 25 mM Tris•HCl buffer, pH 7.5. TmTruB generally eluted at 
250–400 mM salt. Fractions bearing TmTruB were tested for RNase 
contamination, and the RNase-free fractions were heat treated for 15 min at 70 °C 
followed by centrifugation (18,000g, 15 min) to pellet precipitated proteins. The 
combined pure fractions of TmTruB were adjusted to 70% nominal saturation with 
solid ammonium sulfate and stored at 4 °C. Immediately prior to use, aliquots of 
the ammonium sulfate suspension of TmTruB were diluted with an equal volume 
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of 25 mM Tris•HCl buffer, pH 7.5, containing sodium chloride (250 mM) and 
desalted by passage over a column of G-25 resin, equilibrated in the same buffer.  
 
RNA substrates 
RNA oligonucleotides were obtained from GE Dharmacon (Lafayette, CO) 
and deprotected according to the manufacturer’s protocol. Following deprotection, 
RNA was desalted by ultrafiltration using a Centricon-3 device to achieve dilution 
of small molecules initially present (>1000-fold) and was further purified by reverse 
phase HPLC over a preparatory C18 column using a gradient of acetonitrile in 25 
mM ammonium acetate buffer, pH 6.0. RNA-bearing fractions were taken to 
dryness in vacuo in a Savant DNA120 speedvac (Thermo Electron), redissolved 
in RNase-free water, and stored as aliquots at -80 °C until further use. 
Digestion and MALDI-MS analysis of TmTruB and TmTSL 
TmTruB. Solutions of wild-type or D39A TmTruB (50 µg) were incubated for 
15 min at 94 °C to denature the protein. The precipitate was then pelleted by 
centrifugation (18,000g, 15 min), and the protein pellet was suspended in 25 mM 
sodium phosphate buffer (100 µL), pH 7.8, containing trypsin (0.01 mg/ml), 
endoproteinase Glu-C (0.02 mg/ml), and acetonitrile (10% v/v). This mixture was 
incubated for 12 h at 25 °C. An aliquot (10 µL) was drawn up into ZipTipC18 pipetter 
tip (Millipore, Bedford, MA) and then expelled; the bound peptides were washed 
(10 × 10 µL) with aqueous trifluoroacetic acid (0.1% v/v) and eluted with Cl-CCA 
matrix solution (5 µL), which was 4-chloro-α-cyanocinnamic acid (6.24 mg/ml) in 
70% aqueous acetonitrile containing trifluoroacetic acid (0.1% v/v). The ZipTip 
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eluate (1 µL) was spotted on a MALDI sample plate, air dried, and analyzed on a 
Voyager DE-Pro MALDI-TOF instrument (PE Biosystems, Foster City, CA). 
Spectra were acquired in positive reflectron mode with an extraction delay time of 
200 ns and 400 laser shots per spectrum. Calibration was achieved using a 1:1:2 
mixture of Bradykinin fragment 1-7 (757.399 m/z), fragment 18-39 of ACTH 
(2465.1989 m/z), and the oxidized β-chain of insulin (3494.6513 m/z) purchased 
from Sigma-Aldrich (St. Louis, MO).  
RNA. An aliquot of RNA (10 µL, 100 µM) was diluted into RNase-free water 
(40 µL) to which RNase T1 (2 µL, 200 U) or RNase A (2 µL, 200 U) was added 
and incubated for 1 h at 37 °C. Following this, alkaline phosphatase (5 µL, 5 U) 
was added to the digestion mixture, which was additionally incubated for 3 h at 37 
°C. An aliquot (3 µL) of the digest was mixed with the 3-HPA matrix solution (3 µL), 
which was 3-hydroxypicolinic acid (3-HPA; Fluka, Milwaukee, WI; 10 mg/ml) in 
50% aqueous acetonitrile. The sample was spotted on a MALDI plate, air dried, 
and analyzed. Mass spectra were acquired either in positive or negative reflectron 
mode; calibration was achieved by a conventional 3-point method using a mixture 
of standard oligonucleotides: TTTGCTT (2076.37 monoisotopic mass), T10 
(2978.49), and T15 (4498.721) purchased from GE Dharmacon. Data was analyzed 
with mMASS data analysis software, version 5.5.1. [68] 
Kinetic analysis of TmTruB 
Standard reaction buffer was 25 mM Tris•HCl buffer, pH 7.5, containing 
sodium chloride (250 mM) and DTT (5 mM). The reaction mixtures (1200-4000 μL) 
were standard reaction buffer containing TmTSL (50-2500 nM). After pre-
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incubation for 3 min at 58 °C, reactions were initiated by the addition of a small 
volume (<6 µL) of TmTruB (to 1.5 nM). Aliquots (300-1000 μL) were removed at 
various time intervals (30, 60, 90, and 120 s) and quenched by extracting TmTruB 
into an equal volume of chilled (4 °C) phenol saturated with 10 mM Tris•EDTA 
buffer, pH 4.5. After a second extraction with 1:1 phenol:chloroform saturated with 
the same buffer, the RNA was precipitated with ethanol, pelleted by centrifugation, 
and air-dried. The pelleted RNA was redissolved in standard reaction buffer (100 
μL), passed through a Corning Costar spin filter (0.22 µm), and analyzed by 
HPLC over a DNAPac® PA200 column connected to an Agilent 1100 HPLC system 
equipped with an IC-3000 binary pump (Dionex, Sunnyvale, CA). RNA samples 
were eluted using a gradient of sodium chloride (100-1.25 M) in 100 mM Tris•HCl 
buffer, pH 9.0, by use of the following program (the first number is the percentage 
of high salt buffer, which is 100 mM Tris•HCl buffer, pH 9.0, containing sodium 
chloride (1.25 M); the second number is the elapsed time in minutes): 0, 26.4; 1, 
26.4; 26, 57.6; 26, 80; 27, 80; 27, 26.4; 40, 26.4.  
Analysis of the TmTruB-[F5U]TmTSL adduct  
TmTruB and [F5U]TmTSL were incubated in standard reaction buffer at      
58 °C. After 3 h, the sample was either heated to 94 °C and held for 5-15 min or 
loaded directly onto the gel. The SDS-PAGE gels (10%) were stained with 
Coomassie blue, and the urea-PAGE gels (12%, 7 M urea) were first stained with 
SYBR® Gold stain (to visualize RNA) followed by Coomassie blue (to visualize 
protein). Occasionally, RNA used in adduct studies was visualized by virtue of the 
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fluorescence of an attached fluorescein (Fl) moiety by purchasing RNA with a 5′-
Fl label. 
The time course for the formation of [F5U*]TmTSL was obtained by 
incubating TmTruB (5 µM) with [F5U]TmTSL (10 µM) in standard reaction buffer at 
58 °C. Aliquots of the reaction mixture (20 µL) were withdrawn at regular time 
intervals and immediately quenched by mixing with 2x Laemmli buffer or 2x RNA 
loading dye (20 µL) and incubating at 94 °C for 5 min. After cooling the tubes on 
ice for 5 min, samples were analyzed by SDS-PAGE and urea-PAGE. Aliquots of 
the reaction mixture (15 µL) were also withdrawn at regular time intervals to test 
for the formation of [F5U*]TmTSL by HPLC analysis. The withdrawn aliquots were 
immediately quenched by the extraction of protein into 1:1 phenol:chloroform as 
described above. The RNA was precipitated from the separated aqueous phase 
with ethanol, pelleted by centrifugation, air-dried, redissolved in water (100 µL), 
and filtered (0.22 µm) for HPLC analysis. 
Size exclusion studies  
TmTruB and size standards were diluted into either 25 mM Tris•HCl buffer, 
pH 7.5, containing sodium chloride (250 mM) or 50 mM sodium phosphate buffer, 
pH 7.0, containing sodium chloride (150 mM) to a final concentration of 2-5 mg/ml 
and loaded on to a HiPrep Sephacryl S-200 HR (16 × 600 mm) size exclusion 
column fit to a BioCAD SPRINT FPLC run by Perfusion Chromatography 
Workstation v3.01; elution was accomplished with the same buffer flowing at 0.4 
mL/min. For studies with the adduct, TmTruB (50 µM) and [F5U]TmTSL (50 µM) 
were initially incubated in standard reaction buffer for 3 h at 58 °C. Following 
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analysis by urea-PAGE to assess adduction, the sample (without dilution) was 
injected onto the Sephacryl S-200 column and eluted isocratically with standard 
reaction buffer. 
 
18O labeling studies 
To allow pre-equilibration of water molecules in the active site with bulk 
solvent, TmTruB (20 µM) was incubated either in standard reaction buffer (250 µL) 
or in the same buffer (250 µL) containing 50% [18O]H2O for 5 min at 58 °C. The 
reaction was initiated by adding a small aliquot (5.6 µL) of [F5U]TmTSL (40 µM). 
After 3 h, an aliquot (60 µL) of the reaction mixture was analyzed by urea-PAGE 
and SDS-PAGE to assess adduct formation, and another aliquot (5 µL) of the 
reaction mixture was diluted into S1 nuclease digestion buffer (95 µL), which is 30 
mM sodium acetate buffer, pH 4.6, containing sodium chloride (50 mM), zinc 
chloride (10 mM), and glycerol (5%, v/v). S1 nuclease (0.5 µL, 50 U) was added, 
and the mixture was incubated for 1 h at 37 °C; the digest was then incubated for 
5 min at 94 °C followed by incubation on ice for 5 min. Subsequently, a fresh aliquot 
of S1 nuclease (1 µL, 100 U) and alkaline phosphatase (3 µL, 3 U) were added, 
and the mixture was incubated for 3 h at 37 °C. The digest was then analyzed over 
an SB-C18 analytical column connected to Beckman Coulter System Gold HPLC 
(Indianapolis, IN) equipped with a model diode array detector.  
For the unlabeled reaction, the remainder of the reaction mixture (185 µL) 
was incubated for 15 min at 94 °C then placed on ice for 5 min. Precipitated 
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TmTruB was pelleted by centrifugation (18,000g, 15 min). The supernatant was 
removed, and residual protein was extracted with 1:1 phenol:chloroform as 
described above. The RNA was precipitated with ethanol, and the resultant pellet 
was washed with cold ethanol (70%, v/v), air-dried, and dissolved in RNase-free 
water (100 µL). To this solution, RNaseT1 (3 µL, 300 U) was added, and the mixture 
was incubated for 1 h at 37 °C. Following this, alkaline phosphatase (5 µL, 5 U) 
was added to the digestion mixture, which was incubated for 3 h at 37 °C. An 
aliquot (3 µL) of the resulting dephosphorylated oligonucleotides was mixed with   
3-HPA matrix solution (3 µL), spotted onto MALDI plate, and air dried for 
acquisition of mass spectra. Another aliquot (0.5 µL) of the digest was mixed with 
the 3-HPA matrix solution (0.5 µL) made with 50% [18O]water, and mass spectra 
were acquired. Finally, an aliquot (3 µL) of the digest was diluted 1:1 with 
[18O]water and incubated for 3 h at 37 °C before mixing with 3-HPA matrix solution 
(3 µL) and analysis by mass spectrometry.  
A part of the pellet (TmTruB) from the unlabeled reaction was suspended in 
25 mM sodium phosphate buffer (50 µL), pH 7.8. To this, trypsin (1 µg) and 
endoproteinase Glu-C (2 µg) were added, and the mixture was incubated for 12 h 
at 25 °C. An aliquot (10 μL) of the digestion mixture was desalted using a ZipTipC18 
as described above, and the bound peptides were eluted in 70% aqueous 
acetonitrile containing trifluoroacetic acid (0.1% v/v). The ZipTip eluate (1 μL) was 
mixed with Cl-CCA matrix solution (1 µL) spotted on a MALDI sample plate, air 
dried, and analyzed. An aliquot of the ZipTip-purified sample (3 µL) was mixed with 
Cl-CCA matrix solution prepared in 50% [18O]water and analyzed. The rest of the 
48 
 
pellet from the unlabeled reaction was suspended in sodium phosphate buffer, pH 
7.8, containing [18O]water (50%, v/v) and digested with trypsin/endonuclease Glu-
C (1 µg/2 µg) as described above. The resulting peptide mixture was desalted and 
concentrated using a ZipTipC18, and an aliquot of the eluate (1 µL) was mixed with 
Cl-CCA matrix solution (1 µL) and analyzed. 
For the labeled reaction, the 18O content of the buffer was either maintained 
at 50% or diluted to 10% prior to heat disruption of the adduct. Following heat 
disruption, the protein and RNA were separated, digested, and analyzed as 
described for the unlabeled reaction. For pre-incubation studies with it, 
[F5U*]TmTSL was prepared by incubating TmTruB (45 µM) with [F5U]TmTSL (70 
µM) in standard reaction buffer (150 µL) for 3 h at 58 °C. Following this, RNA was 
isolated as described above and purified over the DNAPac PA200 column. Purified 
[F5U*]TmTSL (10 µM) was then pre-incubated in standard reaction buffer 
containing [18O]water (50%, v/v), and TmTruB (10 µM) was added immediately 
prior to heat-treating the mixture for 15 min at 94 °C. Following this, RNA and 









Subcloning, overexpression, and purification of TmTruB 
The expression vectors pUL390 and pUL391 were created to encode wild-
type and D39A TmTruB, respectively, with an N-terminal His6•tag. Both proteins 
were overexpressed by standard methods, [64] and TmTruB was purified to near 
homogeneity by nickel affinity chromatography followed by anion exchange 
chromatography and heat treatment (Figure 2.5). The final step was possible 
because TmTruB is thermostable whereas the impurities (E. coli cellular proteins) 
are denatured by heat and then easily removed by centrifugation. Initially, the 
concentrations of TmTruB were determined by biuret assay [69] and the method 
of Gill and von Hippell [70], which uses A280  of denatured protein and a calculated 
sequence-dependent extinction coefficient. These values were in reasonable 
agreement and used to determine ε280 for the native protein and a conversion 
factor for the Bio-Rad protein assay with bovine serum albumin as the standard. 
[71] Subsequently, A280 or the Bio-Rad assay were used to determine the 
concentration of TmTruB. For long-term stability, pure fractions of TmTruB were 
pooled and concentrated to 2-5 mg/ml, and ammonium sulfate was added to 
nominal 70% saturation. Of several storage conditions tested, this one was found 
to be superior as judged by periodic activity assays. [72] Under these conditions, 






Figure 2.5: SDS-PAGE analysis of the overexpression and purification of 
TmTruB (37.6 kDa). A, Overexpression of TmTruB. B, Purified fractions of 
TmTruB. MW, EZ-Run protein markers (Fisher Scientific; Waltham, MA). 
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Kinetic characterization of TmTruB 
The kinetic characterization of TmTruB had not been previously reported, 
so the first goal was to determine kcat and Km for comparison with those of its 
mesophilic homolog EcTruB. In order to establish a convenient and informative 
assay, several conditions had to be optimized, including quench methodology, 
temperature, substrate, and reaction buffer. 
Quench conditions 
Most fundamentally, a discontinuous assay requires an efficacious 
quenching of the reaction, so several quench conditions were scouted. Heat was 
excluded as an efficient quencher because T. maritima is an extremophile that 
grows optimally at 65-90 °C. [73] Quench by the extraction of protein with phenol 
was found to be effective and convenient. The efficacy of phenol quench was 
verified by analyzing time points for each assay immediately after addition of 
TmTruB to initiate the reaction. HPLC analysis of these time points showed <1% 
conversion of substrate (TmTSLU) to product (TmTSLΨ). 
Reaction temperature and choice of substrate 
Generally, an assay temperature should be in close proximity to the growth 
optimum for the host organism, which is 60-85 °C for T. maritima. Furthermore, 
since the RNA substrate needs to adopt its folded conformation to be handled by 
TmTruB, the assay temperature must be at least several degrees below the 
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melting temperature (Tm)2 of the substrate to assure a preponderance of folded 
RNA. Three different TSL substrates from E. coli, T. maritima, and T. thermophilus 
tRNAs were scouted for this purpose (Figure 2.6). The TSL from T. maritima 
tRNAPhe (TmTSLU) was chosen because it has a suitable melting temperature  
(Tm= 68–72 °C) and represents the exact sequence of one TmTruB substrate 
(tRNAPhe). [74] The optimal reaction temperature was found by incubating TmTruB 
(25 nM) with TmTSLU (1 µM) at various temperatures (4–85 °C) in standard 
reaction buffer for 1 h followed by measurement of the amount of product 
(TmTSLΨ). To achieve that end, the RNA was digested with S1 nuclease and 
alkaline phosphatase. The resulting nucleosides were separated by HPLC over a 
C18 column with quantification by A260 normalized using 280 of the nucleosides 
(Figure 2.7, panel A). For the reactions run between 50 and 85 °C, complete 
conversion was observed after 1 h. A reaction temperature of 58 °C was chosen 
because it was convenient and well below the melting temperature of TmTSLU.  
RNA digestion 
The measurement of the concentration of TmTSLΨ with minimal 
manipulation and maximal sensitivity would be best. The preliminary assays 
described above relied on digestion of TSL E. coli tRNAPhe to its component 
nucleosides and their quantitation. Although effective, this method requires 
digestion, and the sensitivity is limited by the absorbance of Ψ. The greater 
absorbance of intact TSL (due to the contribution of all 17 component nucleosides) 
                                                
2 The melting temperature (Tm) is the temperature at which half of the RNA population is in 
the folded conformation (hairpin loop) and half is denatured. 
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enhances sensitivity, and the absence of a digestion step is clearly more 
convenient. Intact E. coli TSLU, however, cannot be separated from E. coli TSLΨ 
despite myriad attempts with a wide array of elution conditions from numerous 
column matrices. Digestion with RNase A or RNase T1 places the product 
nucleoside in a smaller oligonucleotide, which maintains some advantage in 
sensitivity (although still requiring an ‘extra’ manipulation) and should allow more 
facile separation of substrate and product since the difference between them is 
now in a context less likely to overwhelm it. However, the oligonucleotide with Ψ 
after digestion of E. coli TSL with either RNase was not readily separated from its 
parent with U. 
Fortunately, intact TmTSL proved more amenable to the needs of the 
assay. In addition to the reasons stated above for choosing it as the standard 
substrate, it was also recommended by the ready separation of TmTSLΨ from 
TmTSLU by chromatography over a mixed hydrophobic/anion exchange column 
(DNAPac PA200). Elution by a gradient of increasing salt yields baseline 
separation of the intact substrate and product stem-loop RNAs (Figure 2.7, panel 
B). 
Reaction buffer and enzyme concentration 
Phosphate buffer and Tris•HCl buffers with pH ranging from 7.0-8.5 and 
variable salt concentrations (100-500 mM sodium chloride or potassium chloride) 
were considered for the assay. TmTruB was considerably slower (>5 fold) in 
phosphate buffer in accord with previous results for other Ψ synthases, [30] so 





Figure 2.6: Stem-loop RNAs tested as substrates for TmTruB. 





Figure 2.7: A, Endpoint (1 h) assays of the activity of TmTruB (25 nM) 
incubated with TmTSLU (1 µM) at different temperatures. B, Time course for 
the reaction of TmTSLU (1 µM) catalyzed by TmTruB (5 nM) at 58 °C.
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TmTruB (1.5-25 nM) was incubated with TmTSL (500-5000 nM) in 25 mM Tris•HCl 
buffer, pH 7.5, containing sodium chloride (125-500 mM). Aliquots of these 
reactions were withdrawn at various time intervals, and product-bearing fractions 
were measured for TmTSLΨ formation. At low salt concentration (125 mM sodium 
chloride), the reaction was extremely fast even at low concentrations of TmTruB 
(complete conversion occurring within <1 min). TmTruB (1.5 nM) was conveniently 
assayed at a somewhat high salt concentration (250 mM), which was adopted as 
the standard reaction buffer. 
Steady state kinetic parameters for TmTruB 
With the various considerations addressed, the final assay described in the 
Experimental section was used to determine kcat and Km for TmTruB. Rates of 
TmTSLΨ formation at variable substrate concentrations (Figure 2.8, panel A; Table 
2.1) were fit to the Briggs-Haldane equation to yield kcat = 0.67 ± 0.02 s-1 and                    






TmTSLU, nM v0, nM•min
-1 
0 0 
150 6.25 ± 0.14 
300 13.02 ± 0.17 
500 18.95 ± 0.17 
1000 28.60 ± 1.50 
2500 41.61 ± 2.10 
  
  






Figure 2.8: Steady state kinetic analysis of TmTruB. A, Initial velocities of 
TmTruB (1.5 nM) for different concentrations of TmTSLU: 2500 nM (□); 1000 
nM (◊); 500 nM (●); 300 nM (Δ); 150 nM (Ο). B, Fit (R2 = 0.999) of the initial 
velocity data for TmTruB to the Briggs-Haldane equation.   
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Adduct formation between TmTruB and [F5U]TmTSL 
To probe adduct formation, TmTruB (2.5-10 µM) was incubated with 
[F5U]TmTSL (2.5-10 µM) in different ratios (1:1, 1:2, 2:1) in standard reaction buffer 
for 3 h at 58 °C and were analyzed by SDS-PAGE (10%) and urea-PAGE (12%, 
7M urea) gels (Figure 2.9). The gel analysis revealed a new, faster-moving adduct 
band that stained for both protein and RNA. SDS-PAGE analysis showed only a 
modest adduction (~33%) even when TmTruB (2.5 µM) was incubated with excess 
[F5U]TmTSL (5 µM). With urea-PAGE, a substantial amount of free TmTruB 
remained despite a consistently higher level of adduction (78%, Figure 2.9), 
although substantial variation in the measured level of adduction was observed 
across replicate trials (Figure 2.10).  
To assess product formation, TmTruB (2.5 µM) was incubated with 
[F5U]TmTSL (5 µM) for 3 h at 58 °C. The RNA was treated with S1 nuclease and 
alkaline phosphatase, and the resulting nucleosides were analyzed by reverse 
phase HPLC. Peaks identical in retention time to the products of F5U from the 
action of EcTruB (F5U*) confirmed the identity of the products from the action of 
TmTruB. To probe its inhibition by [F5U]RNA, [F5U]TmTSL (5 µM) was pre-
incubated with TmTruB (2.5 µM) in standard reaction buffer (50 µL) for 3 h at 58 
°C. A small aliquot (2.4 µL) of the mixture was assayed by incubation with TmTSLU 
(5 µM) in standard reaction buffer (300 µL). Aliquots of this reaction withdrawn at 
various times and analyzed by HPLC revealed a substantial reduction (~8 fold) in 





Figure 2.9: Denaturing PAGE analysis of adduct formation. A, SDS-PAGE. B, 
Urea-PAGE stained with SYBR® Gold. C, Urea-PAGE stained with Coomassie 




Figure 2.10: A-E, Replicates of adduction trials with TmTruB (40 µM) and 
[F5U]TmTSL (20 µM) and analysis by urea-PAGE (15%, 7M urea). F, 
Adduction trial with TmTruB (20 µM) and [F5U]TmTSL (20 µM). The 
quantitation of adduct, to free protein, and free RNA is summarized in 
Table 2.2. 5′-Fluorescein-labeled [F5U]TSL was used in the experiments 

















2:1 52.3 47.7 39.8 60.2 
2:1 52.6 47.4 65.4 34.6 
2:1 53.6 46.4 67.7 32.3 
2:1 58.4 41.6 94.8 5.2 
2:1 63.8 36.2 95.3 4.7 
2:1  39.8a  60.2a 48.5 51.5 
1:2 54.6 45.4 76.9 23.1 
mean  55.9  44.1   69.77 30.23 
 
  
Table 2.2: Changing ratios of adduct to free protein and free RNA were 
observed on urea-PAGE gels (Figure 2.10; 15%, 7M urea) for replicates of 
TmTruB (40 µM) and [F5U]TSL (20 µM) incubations. 
 
a







Figure 2.11: Inhibition of TmTruB by [F5U]TmTSL.  
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Size exclusion chromatography 
Size exclusion chromatography separates molecules based on their size 
(molecular weight, Mr) and shape. The elution of a certain sample is usually 
characterized by the partition coefficient (Kav), which is related to the size of the 
molecule (Figure 2.12). [75] Standard proteins can be used to create a calibration 
curve with Kav plotted against log(Mr) to determine the apparent Mr of the protein 
of interest. [75]  
One possible explanation for substoichiometric adduct formation is a 
distribution between reactive and unreactive states of TmTruB. In particular, the 
unbound protein band on denaturing gels could arise from inactive dimer (or a 
higher multimeric form) of TmTruB. To probe this possibility, Mr for TmTruB was 
assessed by size exclusion chromatography in both standard reaction buffer and 
in 50 mM sodium phosphate buffer, pH 7.0, containing sodium chloride (150 mM) 
(as recommended by the column manufacturer). Molecular weight standards were 
used to generate a calibration curve with which Mr for TmTruB was calculated 
based on its elution volume, Ve (Figure 2.14). In phosphate buffer, the apparent 
molecular weight of TmTruB (40.5 kDa) does not differ markedly from the 
theoretical monomeric value (37.6 kDa) (Figure 2.12, panel A), but the value in 
standard reaction buffer was distinctly lower (25.0 kDa) (Figure 2.13, panel B).  
Size exclusion studies were also performed on the TmTruB-[F5U]RNA 
adduct, which was prepared by incubating TmTruB (50 µM) with [F5U]TmTSL       






Figure 2.12: Theoretical trace for size exclusion chromatography. From 
GE Healthcare manual 18-1022-18. 
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Figure 2.13: Overlay of traces from size exclusion chromatography of 




Figure 2.14: Plot of Kav versus log(Mr) for standards and TmTruB. A, Run 
in phosphate buffer. B, Run in Tris buffer. 
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displayed very similar Ve (62 mL, 64 mL, and 58 mL, respectively; Figure 2.15), 
making it very difficult to differentiate the adduct from free RNA and protein. 
Denaturing PAGE analysis of the eluted fractions (42-70 mL) from the run with the 
adduct showed free TmTruB, free RNA, and the adduct, which suggests co-elution 
(Figure 2.16). 
Time course for the formation of [F5U*]TmTSL 
The size exclusion chromatography results seem to disfavor the hypothesis 
that an inactive TmTruB dimer accounts for the free protein seen by denaturing 
PAGE, which raises the possibility that some fraction of TmTruB is simply 
incapable of interacting with [F5U]RNA because of some unknown post-
translational event. To address this question, TmTruB (5 µM) was incubated with 
an excess of [F5U]TmTSL (50 µM), and the ratio of adduct to free protein was 
monitored over time by urea-PAGE. This analysis revealed surprisingly fast adduct 
formation, with ~50% of TmTruB in the adduct form by the time first aliquot was 
withdrawn (5 min), the ratio of adduct to free protein and RNA slowly increased 
over the course of 3 h (Table 2.3; Figure 2.16). In apparent contradiction, the HPLC 
analysis revealed >90% conversion of [F5U]TmTSL into its hydrated product, a 
level that held constant and which requires more than 9 turnovers by each active 
site; the first turnover occurred within 5 min (Figure 2.17).  
 





Figure 2.15: Size exclusion chromatography studies of the TmTruB- 
[F5U]TmTSL adduct. A, Traces of the adduct, free TmTruB, and free 
[F5U]TmTSL. B, Gel analysis showing that all [F5U]TmTSL is adducted 




 TmTruB [F5U]TmTSL 
time, min adduct, % free protein, % adduct, % free RNA, % 
0 0 100 0 100 
5 48.1 51.9 68.4 31.6 
10 46.4 53.6 67.5 32.5 
30 59.4 40.6 80.7 19.3 
60 64.4 35.6 87.5 12.5 
120 64.6 35.4 74.6 25.4 




Table 2.3: Distribution of adduct, free TmTruB, and free [F5U]TmTSL 





Figure 2.16: Urea-PAGE (12%, 7M urea) analysis of the reaction between 
TmTruB (5 µM) and [F5U]TmTSL (50 µM). A, The gel was stained with 
SYBR® Gold to visualize RNA. B, The same gel was then stained with 















Figure 2.17: Time course for the conversion of [F5U]TmTSL (50 µM) upon 
incubation with TmTruB (5 µM). A, HPLC traces showing the increase in 
F5U* with time. B, Plot showing the amount of [F5U*]TmTSL as a 




18O labeling studies 
Characterization of TmTruB and [F5U]TmTSL by mass spectrometry 
Monitoring 18O incorporation into RNA or protein by mass spectrometry 
requires a clear window in the mass spectrum. An overlap of the peptide containing 
Asp-39 with other peptides would interfere with the detection of 18O incorporation, 
and the digestion of product RNA provides isotopic resolution and improved 
sensitivity.  
Different proteolytic enzymes and digestion conditions were tried to get peptides 
containing the conserved Asp (Asp-39) in a clear window. The proteolytic digestion 
of thermophilic TmTruB proved extremely difficult as the enzyme resisted 
proteolysis by trypsin, chymotrypsin, endoproteinase-GluC, or pepsin under 
conventional conditions. Denaturation of TmTruB prior to proteolytic digestion 
using guanidinium chloride, trichloroacetic acid, or urea also failed to deliver 
suitable digestion. Ultimately, the combination of trypsin and endoproteinase Glu-
C (hereafter “trypsin/Glu-C”) yielded two peptides that matched the expected mass 
of proteolytic fragments containing Asp-39. The identity of these peptides could 
not be confirmed by MS/MS methods, probably due to inadequate sensitivity and 
the hydrophobicity of these peptides. [76] To confirm the identity of the putative 
peptides containing Asp-39, D39A TmTruB was overexpressed, purified, and 
subjected to trypsin/Glu-C digestion. The expected shift of 39 Da for the peptides 
confirmed their identity (Figure 2.18). For [F5U]TmTSL, digestion with RNase T13 
                                                
3 RNase T1 specifically cleaves RNA after the nucleotide G.  
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delivered the oligonucleotide containing F5U in a clear mass spectral window 
(U[F5U]CG, 1219.23 monoisotopic mass; Figure 2.20, panel A). For the 
trypsin/Glu-C digestions, sequence coverages of 73% and 89% were observed, 
respectively, for wild-type TmTruB (Table 2.4) and D39A TmTruB (Table 2.5). 
Controls for 18O exchange 
Control experiments were run to exclude the exchange of the 18O label 
between Asp-39 and the solvent molecules on the timescale of reaction workup 
and mass spectral acquisition. An aliquot (10 µL) of TmTruB digested with 
trypsin/Glu-C was mixed with [18O]water (10 µL) and incubated for 3 h at room 
temperature prior to analysis. Also, an aliquot (3 µL) of the trypsin/Glu-C digestion 
of TmTruB was mixed with Cl-CCA matrix solution (3 µL) made with [18O]water 
(50%, v/v) and analyzed. These control experiments showed no incorporation of 
18O into the peptides containing Asp-39, thereby excluding the possibility of oxygen 
exchange with solvent under the reaction conditions and analysis. To ensure the 
isotopic content of the [18O]water and assure that methods are sufficiently sensitive 
to detect 18O incorporation, TmTruB was digested with trypsin/Glu-C in 25 mM 
sodium phosphate buffer, pH 7.8, containing [18O]water (50%, v/v) and analyzed. 
As expected, 18O was incorporated into the C-termini of proteolytically-generated 
peptides (Figure 2.19, panel C).  
Similar control experiments were performed with [F5U]TmTSL. To eliminate 
the possibility of 18O exchange with solvent on the timescale of RNA isolation and 




Figure 2.18: Partial mass spectrum of the trypsin/Glu-C digestion peptides 
from TmTruB showing the peptide containing Asp-39 
(32KVGHGGTLDPFACGVLIIGVNQGTR55). Lower spectrum, wild-type 










Table 2.5: Sequence coverage for the trypsin/Glu-C digest of D39A TmTruB. 
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mixed with [18O]water (10 µL), incubated for 3 h at room temperature, and 
analyzed. To eliminate the possibility of 18O exchange between solvent and RNA 
during mass spectral acquisition, an aliquot (3 µL) of the RNase T1-digested and 
dephosphorylated [F5U*]TmTSL was mixed with 3-HPA matrix solution (3 µL) 
made with [18O]water (50%, v/v). The mass spectra showed no incorporation of 
18O into the F5U* containing oligonucleotide (or any others). 
TmTruB 
Once the control experiments delivered satisfactory outcomes, TmTruB (10 
µM) was incubated with [F5U]TmTSL (40 µM) in standard reaction buffer (250 µL) 
made with [18O]water (50%, v/v) for 3 h at 58 °C, and the reaction mixture was 
heated for 15 min at 94 °C to disrupt the adduct. After centrifugation, the 
supernatant was removed, and the pelleted TmTruB was resuspended, digested 
with trypsin/Glu-C, mixed with Cl-CCA matrix solution, and analyzed. If ester 
hydrolysis occurs and 18O gets incorporated into the Asp-39 containing peptide, 
the isotopic composition for this peptide should match that of the reaction buffer 
(50% 18O). Instead, the mass spectrum for this labeled reaction (Figure 2.19, panel 






Figure 2.19: Partial mass spectra of trypsin/Glu-C digestion peptides for 
TmTruB showing 33VGHGGTLDPFACGVLIIGVNQGTR55 (2381.1 mono-
isotopic mass). A, Reaction and disruption in unlabeled buffer. B, Reaction 
and disruption in buffer containing [18O]water (50%, v/v). C, Reaction and 
disruption in unlabeled buffer with proteolysis in buffer containing 
[18O]water (50%, v/v). The line diagrams to the right of spectra represent 




Prior to heat-disrupting the adduct, the 18O content of the reaction was either 
maintained at 50% (v/v) or diluted to achieve 10% (v/v) final composition. Following 
15 min at 94 °C, the RNA was freed of denatured TmTruB by centrifugation, 
digested with RNase T1, dephosphorylated with alkaline phosphatase, and 
analyzed by mass spectrometry. If the oxygen atom in F5U* comes directly from 
solvent, the extent of 18O incorporation would mirror the isotopic composition of 
the buffer (50% or 10%). 
For the reaction run in labeled buffer, the RNaseT1 digests of both samples 
(50% and 10%; Figure 2.20, panel C and D) explicitly show that 18O is incorporated 
into RNA directly from the solvent. However, these experiments did not clarify the 
timing of 18O incorporation—whether it is during the formation or the disruption of 
the adduct. The reaction run in unlabeled buffer and heat-disrupted in buffer 
containing [18O]water (50%) (Figure 2.20, panel E) shows that 18O incorporation 
depends on the composition of the buffer during the disruption step. However, 
given the 1:4 TmTruB:[F5U]TmTSL reaction stoichiometry and based on 50% 
adduction as judged by the urea-PAGE analysis of this sample (data not shown), 
only 1/8 of the total RNA should incorporate 18O. In other words, the percentage of 
18O incorporation was higher (50%) than expected (12.5%).  
To make sure the unusual amount of 18O incorporation into RNA was not 
introduced by an error in the calculation of relative isotopic intensities, the RNase 




Figure 2.20: Partial mass spectra of the RNase T1-digested [F5U]TmTSL 
showing the oligonucleotide containing the F5U (U[F5U]CG; 1217.17 m/zpred). 
A, [F5U]TmTSL. B, [F5U*]TmTSL from reaction in unlabeled buffer. C, 
[F5U*]TmTSL from reaction in buffer containing [18O]water (50%, v/v) 
followed by dilution to 10% 18O prior to digestion. D, [F5U*]TmTSL from 
reaction in buffer containing [18O]water (50%, v/v) and digested without 
isotopic dilution. E, [F5U*]TmTSL from reaction in unlabeled buffer and 
disruption in buffer containing [18O]water (50%, v/v).  
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was purified using reverse phase HPLC, and the fractions bearing F5U*-containing 
oligonucleotide were pooled, concentrated, and analyzed. This additional step of 
purification resulted in mass spectra with greater intensity and better isotopic 
resolution. However, the calculated isotopic composition of the F5U* matched the 
results prior to the HPLC purification, suggesting that the observed results were 
not artifactual. 
TmTruB can handle [F5U*]TmTSL 
For the adduction reaction run in unlabeled buffer and heat disrupted in 
standard reaction buffer made with [18O]water (50%, v/v), the unexpectedly high 
incorporation of 18O into F5U* (Figure 2.20, panel E), is possible only if TmTruB is 
able to handle [F5U*]TmTSL in solution. In other words, not only does TmTruB 
handle [F5U]TmTSL, but it can also dehydrate and rehydrate F5U*, thereby altering 
its isotopic composition to match that of the solvent. For this to happen, TmTruB 
must be active toward [F5U*]TmTSL during the initial stages of heating to disrupt 
the adduct. To test this theory, [F5U*]TmTSL was incubated in labeled buffer, and 
TmTruB was added shortly before heat treatment followed by the isolation of RNA, 
digestion, and analysis. The mass spectrum showed 18O incorporation (50%) into 








Figure 2.21: Partial mass spectra for the RNase T1 digests of [F5U*]TmTSL. 
A, Adduction reaction and heat disruption in buffer containing [18O]water 
(50%, v/v). B, Pre-formed [F5U*]TmTSL incubated with TmTruB in buffer 





Table 2.6: Relative isotope intensities for U[F5U*]CG under different 18O 




Kinetic characterization of TmTruB 
An effective assay was developed for the kinetic characterization of 
TmTruB. The kinetic parameters, kcat = 0.67 ± 0.02 s-1 and Km = 1112 ± 58 nM 
reveal TmTruB at 58 °C to be a better catalyst than EcTruB and RluA at 37 °C 
(Table 2.7). [29, 30, 64] These kcat and Km values were obtained at a relatively high 
salt concentration (250 mM). At a salt concentration (125 mM sodium chloride) 
similar to that used for the assay of EcTruB and RluA (100 mM ammonium 
chloride), TmTruB had such greater activity that it proved impractical to determine 
the initial velocities. 
Adduct formation between TmTruB and [F5U]TmTSL  
The formation of a covalent adduct between TmTruB and [F5U]TmTSL was 
explored by denaturing PAGE and HPLC analysis. The SDS-PAGE and urea-
PAGE gels showed a new band that contained both protein and RNA. Also, 
TmTruB pre-incubated with [F5U]TmTSL showed a continuing decrease in catalytic 
activity that suggests TmTruB gets increasingly inhibited upon exposure to 
[F5U]RNA. However, TmTruB could never be completely driven into the adduct as 
judged by denaturing PAGE (Figure 2.9). This failure to achieve complete 
adduction raises the question of whether the adduct is noncovalent, although it 
seems implausible for a noncovalent adduct to survive the denaturing conditions 
of SDS and urea-PAGE gels. This behavior of TmTruB (partial adduction) could 
arise for two reasons. First, TmTruB may need to adopt a specific conformation  
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Enzyme kcat, s-1 Km, nM 
TmTruB 0.67 ± 0.02 1112 ± 58 
EcTruB 0.24a 800a 
 0.12 ± 0.01b 146 ± 14b 
RluA 0.067 ± 0.003 308 ± 66 
 
aWith TSL [29] 
bWith full length tRNA transcript [64] 
  
Table 2.4: Kinetic parameters obtained for TmTruB in comparison 
to those for EcTruB [18, 22] and RluA. [21] 
 
 
Table 2.7: Kinetic parameters obtained for TmTruB in comparison to
hose for EcTruB [29, 64] and RluA. [30] 
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to bind RNA, and only a part of the protein exists in such a conformation at any 
given time. 2) Part of TmTruB (the free protein seen on gels) may exist as a dimer 
or some other multimeric form of TmTruB that cannot bind RNA. To assess 
whether TmTruB exists as a dimer, size exclusion chromatography was used to 
measure the apparent Mr for TmTruB. These studies surprisingly revealed different 
estimations of Mr for TmTruB in phosphate buffer (40.5 kDa) and Tris•HCl buffer 
(25.0 kDa) compared to the theoretical monomeric value (37.6 kDa; Figure 2.14). 
Two alternative hypotheses could account for this observed discrepancy in 
the molecular weight of TmTruB. The crystal structure (Figure 2.15) shows that the 
shape of TmTruB is distinctly rod-like rather than spherical, [47] which should lead 
to greater penetration into the pores of the size exclusion resin and therefore an 
anomalously low apparent molecular weight. In this scenario, the apparent 
molecular weight of TmTruB is distinctly underestimated in both buffers, and 
TmTruB is a monomer in Tris•HCl buffer but a dimer in phosphate buffer, which 
could be mimicking the phosphodiester backbone of RNA substrate. TruA, a 
member of a different family of Ψ synthases, appears to be a dimer in the crystal 
structure and behaves so in gel filtration in phosphate buffer.[77] In that case, the 
interaction between the dimers was such to make the oligomer more nearly 
spherical, but the putative TmTruB dimer would have to be an association of 
monomers that maintains an elongated shape to explain the data. This hypothesis 
seems less likely than the following one. The decrease in the apparent molecular 
weight of TmTruB in Tris versus phosphate buffer arises from a conformational 
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change, likely because the phosphate buffer mimics the phosphodiester backbone 
of RNA.  
The crystal structures of TmTruB with and without [F5U*]RNA bound (Figure 
2.22) show movement of a small domain (indicated by the arrow). In the apo form, 
the domain is tucked down next to the body of TmTruB but is flipped up and away 
from the body of TmTruB to interact with RNA. If phosphate induces an 
approximation of the latter conformation, it would decrease the penetration of 
TmTruB into the pores of the size exclusion resin and increase the apparent 
molecular weight (to that expected for a globular protein in order to explain the 
data). If the change in the apparent Mr of TmTruB in Tris buffer arises from a 
conformational change and the protein is truly monomeric, a population of TmTruB 
dimer (or higher oligomer) unable to react with [F5U]RNA can account neither for 
the unbound TmTruB observed in SDS-PAGE gels nor the lack of correlation 
between the stoichiometry of product and adduct formation. 
Implications for the turnover of [F5U]TmTSL by TmTruB 
The urea-PAGE analysis of the time course for the formation of 
[F5U*]TmTSL shows a slow but continually increasing ratio of adduct to free 
components over 3 h (Table 2.3). Also, the HPLC analysis of the time course 
performed in parallel to the gel analysis revealed that TmTruB achieves multiple 
turnovers of [F5U]RNA just like EcTruB does. Similar to the urea-PAGE analysis, 
activity assays show that TmTruB—unlike EcTruB—gets increasingly inhibited 
upon exposure to [F5U]RNA.While it is unlikely for a noncovalent adduct to survive   
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Figure 2.22: Crystal structures of TmTruB. A, Bound with RNA. B, 
Unbound. Comparison of the two structures shows a conformational 
change in a small domain (green, indicated by the arrows), which is tucked 
down in the unbound TruB but flipped away to interact with RNA in the 
bound form. 
A                                              B 
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the denaturing conditions of gel electrophoresis, the seemingly contradictory 
results suggest that the adduct forms reversibly. The observation of the adduct on 
denaturing PAGE gels and the inhibition of TmTruB suggest that the adduct is 
covalent. The continuously changing ratio of adduct to free components on 
denaturing PAGE gels implies reversible adduction.  
18O labeling studies 
The 18O labeling studies with TmTruB show the incorporation of label into 
RNA rather than the conserved Asp. These results conclusively demonstrate that 
the additional oxygen atom in F5U* comes directly from solvent rather than from 
the conserved Asp through ester hydrolysis, as found previously with EcTruB, 
RluA, and TruA. [25, 42, 66] Such results strongly disfavor ester hydrolysis as the 
cause of hydration of F5U even in case of TmTruB. Unlike the case with the Ψ 
synthases examined earlier, the 18O content of F5U* reflects the isotopic 
composition of the last water in which TmTruB encountered the RNA. This unique 
result can arise from the following scenario. TmTruB releases unhydrated but 
rearranged F5U whether it initially binds [F5U]TmTSL or [F5U*]TmTSL, and the 
released species spontaneously hydrates in solution. In other words, TmTruB can 
both rearrange F5U and dehydrate F5U*. This continuous dehydration/rehydration 
of F5U* nicely explains the apparent discrepancy in the percentage of 18O content 
incorporated into F5U*. The binding equilibrium between TmTruB and [F5U]TmTSL 
or [F5U*]TmTSL is poised such that substantial amounts of free and bound enzyme 
are observed in denaturing gels. The existence of such a binding equilibrium is 
supported by the changing ratios of adduct to free TmTruB seen by urea-PAGE 
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with time (Figure 2.15) and in replicates (Figure 2.10), which indicates an exquisite 
sensitivity to fine variations in the reaction and gel conditions. Bound enzyme is 
inhibited in activity towards TmTSLU (Figure 2.10), but free enzyme is sufficiently 
abundant to achieve multiple turnovers of [F5U]TmTSL as seen in the HPLC 
analysis for the formation of [F5U*]TmTSL (Figure 2.17). This makes the behavior 
of TmTruB intermediate between that of EcTruB (no observed adduct; multiple 
turnovers) and RluA and TruA (stoichiometric adduction; single turnover). 
Helm and co-workers [78] recently hypothesized that the TmTruB-[F5U]RNA 
adduct is noncovalent based on spectroscopic studies using RNA decorated with 
fluorophores at different sites. [78] Those investigators did not observe an adduct 
between TmTruB and [F5U]RNA on urea-PAGE, which led them to conclude that 
the adduct is not stable enough to be covalent. [78] However, adduction is clearly 
shown here by both urea- and SDS-PAGE, although the levels were variable and 
the maximal level of adduct varied with the gel denaturant. Furthermore, Helm and 
co-workers used a lower percentage gel (10% versus 15%) and full-length tRNA 
transcript rather than stem-loop, which may contribute to the apparent 
discrepancy. The ability of the TmTruB-[F5U]TmTSL adduct to withstand the 
denaturing gel conditions supports the covalency of the adduct, even though a 
covalent bond was not visualized in the crystal structure of TmTruB with [F5U]RNA. 
[47] When Helm and co-workers observed a fast-forming band on SDS-PAGE 
gels, they reasonably concluded that such rapid formation of a covalent complex 
is precluded for an enzyme as slow as TruB. [78] Their conclusion was based on 
the kinetics of EcTruB, but TmTruB is a more efficient catalyst than its mesophilic 
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homolog (Table 2.7), so rapid formation of the TmTruB-[F5U]TmTSL adduct is not 
surprising. Also, Helm and co-workers initially assumed that TmTruB suicidally 
forms a covalent intermediate, but the collective results reported here imply that 
TmTruB and [F5U]RNA form a covalent adduct but do so reversibly.  
The (still) consistent scheme for handling of F5U 
Recently, Stroud and co-workers reported a cocrystal structure for RluB and 
[F5U]RNA in which a covalent adduct was found between the hydroxyl group of 
Tyr-146 and the pyrimidine ring of F5U (Chapter 1, [46]). Their results led them to 
the conclusions similar to the consistent scheme proposed by the Mueller group 
for the handling of F5U by Ψ synthases (Figure 2.23). The data reported here for 
TmTruB nicely fits the scheme. By any mechanism, TmTruB rearranges F5U to the 
C-glycoside. By virtue of the electrophilic C6, the rearranged F5U either gets 
trapped by an active site nucleophile (Tyr-146 in RluB; putatively the conserved 
Asp in RluA, TruA, and TmTruB), or gets released into solution and undergoes 
spontaneous hydration. After releasing [F5U*]TmTSL, TmTruB either binds 
[F5U]TmTSL or rebinds [F5U*]TmTSL for dehydration/rehydration. All data is 









Figure 2.23: The slightly revised scheme of Mueller and co-workers that 









DEUTERIUM WASH-IN STUDIES TO PROBE THE GLYCAL 
MECHANISM 
 
Pseudouridine synthases (Ψ synthases) rearrange 5-fluorouridine in RNA 
to its C-glycoside isomer just as they rearrange uridine to pseudouridine (Ψ). The 
behavior of different Ψ synthases differ towards [F5U]RNA. TruA and RluA get 
irreversibly inhibited in handling [F5U]RNA and form an adduct that appears 
covalent by denaturing PAGE analysis. [29, 30, 36] E. coli TruB (EcTruB), on the 
other hand, is not inhibited by [F5U]TSL4 but instead converts F5U into two 
rearranged, hydrated products (hereafter, the major and minor products).[25] T. 
maritima TruB (TmTruB) shows an intermediate behavior. TmTruB is only partially 
adducted at any given time, and enough free enzyme remains to perform multiple 
turnovers to generate the same major and minor products delivered by the action 
of EcTruB (Chapter 2).  
                                                
4 E. coli TruB was previously shown to handle T-arm stem loop tRNAPhe (TSL) as an 




Initially, two different mechanisms were proposed for the Ψ synthases. In 
the Michael mechanism, the conserved Asp attacks C6 of the pyrimidine ring of 
F5U to form a covalent Michael adduct (Figure 1.4), and rearrangement to the        
C-glycoside isomer and deprotonation of C5 complete the reaction. [36] In the 
acylal mechanism, the conserved Asp instead attacks C1′ of the ribose ring to form 
an acylal intermediate (Figure 1.6); the detached uracilate anion then undergoes 
a net 180° rotation to reposition itself for C-glycoside formation to generate Ψ. [36]  
Miracco and Mueller showed that the major product was the rearranged, 
hydrated species seen in the cocrystal structure of TruB with [F5U]RNA (Figure 
3.1), [40] but the minor product was an arabino isomer of the major product, 
differing from it in the configuration at C2′ of the pentose ring (Figure 3.1). [43] The 
minor product therefore requires epimerization at C2′, so the mechanism must 
proceed through a glycal intermediate that is reprotonated on the opposite face to 
yield the observed arabino product. [43] With [F5U]RNA, the observed arabino 
product can be explained as part of the acylal mechanism. The increased acidity 
of 5-fluorouracil translates into reduced nucleophilicity for its anion relative to the 
uracilate anion, so the lifetime is lengthened for both the acylal intermediate and 
the oxocarbenium ion with which it is in equilibrium. [43] The increased acidity of 
C2′ in the latter species makes it easier for the free—and therefore available—
conserved Asp to deprotonate C2′ from the “top” to form a glycal intermediate 
(Figure 3.2). Reprotonation from the “bottom” yields the arabino product of F5U.  
The cocrystal structures of several Ψ synthases with [F5U]RNA reveal the 




   
Figure 3.1: The identity of the major and minor products of F5U differ at 
the stereo configuration of C2′. [43] 
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Figure 3.2: The acylal mechanism recast to emphasize features that can 
account for the arabino product of F5U. The boxed manifold exists only 
for F5U because of the increased life time of the oxocarbenium ion that is 
in equilibrium with the acylal intermediate. [43] 
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so able to deliver a proton to the “bottom” face. Because the Michael mechanism 
has the conserved Asp tied up in an ester bond at this point, it cannot ferry a proton 
to the “bottom” face of the glycal to effect reprotonation. Therefore, the arabino 
product of F5U strongly disfavors the Michael mechanism. 
 If a glycal intermediate forms during the conversion of U to Ψ as it does 
during the reaction of F5U, an alternative mechanism arises: the ‘glycal’ 
mechanism (Figure 3.3), which can readily account for both the major and minor 
products of F5U (Figure 3.4). Uridine phosphorylase offers an enzymatic precedent 
for a glycal intermediate in the reaction of nucleotides. [44]. The deprotonation of 
C2′ to form the glycal intermediate can be achieved by either the conserved Asp 
or the O2 on the pyrimidine ring. [44] Following the C-glycoside rearrangement, 
reprotonation of the pentose ring at C2′ generates Ψ (Figure 3.3).  
Deuterium wash-in 
If the reaction of [F5U]RNA with Ψ synthases proceeds through a glycal 
intermediate with the conserved Asp acting as a base to deprotonate C2′, the 
removed proton resides temporarily on the Asp, where it may be prone to 
exchange with the solvent protons (Figure 3.5) [79, 80]. If this is true, an observed 
deuterium “wash-in” would provide evidence for a glycal intermediate along the 
reaction pathway.  
When TruB and RluA were incubated with U- and F5U-containing RNA, the 
mass spectra for the reactions run in unlabeled (H2O) and labeled buffer (D2O) 




Figure 3.3: The proposed ‘glycal mechanism’ for Ψ formation. The 
conserved Asp initiates the reaction by deprotonating C2′ that leads to a 
glycal intermediate. After the C-glycoside rearrangement, C2′ is 





Figure 3.4: The ‘glycal’ mechanism with [F5U]RNA. Reprotonation from the 





Figure 3.5: Deuterium wash-in scheme for the glycal mechanism with F5U. 
If the proton on the conserved Asp can exchange with solvent on the time 
scale of the conversion of F5U to its products, deuterium wash-in should 






Figure 3.6: Mass spectra for the deuterium wash-in studies on RluA with 
RNAs containing U (left) and F5U (right). [10] In neither case was 
deuterium wash-in observed. 
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the lack of wash-in remains consistent with a glycal intermediate because the 
conserved Asp may be occluded from the solvent on the timescale of the 
conversion of U to Ψ or F5U to F5U*. A careful literature review revealed that Y76L 
TruB offers an opportunity to probe this matter further. 
Y76L TruB 
The Ψ synthases show a conserved aromatic amino acid residue, which is 
a tyrosine in five of the six families and a phenylalanine in the TruD family. 
Phannachet et al mutated this tyrosine residue in E. coli TruB. The Y76F, Y76L, 
and Y76A variants lost the natural activity towards U, but Y76F and Y76L TruB still 
handle F5U. [51] Although Y76F TruB generates both the major and minor products 
of F5U, the Y76L TruB interestingly produces only the major product and does so 
slowly (Figure 3.7).[51] Phannachet et al. did not to pursue this unusual behavior 
further, but it makes Y76L TruB ripe for deuterium wash-in studies for two reasons. 
First, if the lack of deuterium wash-in observed with wild-type TruB and RluA was 
due to the exclusion of solvent from the active site, the alteration in the geometry 
of the active site caused by the Y76L mutation might provide a path for solvent 
molecules to enter the active site, thereby resulting in deuterium wash-in. Second, 
the slower catalysis supported by Y76L TruB with [F5U]TSL will provide more time 
for the solvent to access the active site, perhaps enough to allow exchange of the 





Figure 3.7: HPLC analysis of reaction products of 5FU-RNA incubated with 
E. coli Ψ55S wild-type or Y76 mutants by Phannachet et al. [11] Each stem-
loop RNA was incubated with the indicated TruB variants, and the product 
RNA was enzymatically digested to nucleosides and analyzed by reverse 






Modified chymotrypsin (sequencing grade) was purchased from Roche 
(Indianapolis, IN). Immobilized pepsin was purchased from Fisher Scientific 
(Waltham, MA). RNA oligonucleotides were obtained from GE Dharmacon 
(Layafette, CO), deprotected according to the manufacturer’s protocol, and purified 
as described in Chapter 2. Deuterium oxide (99.9%) was obtained from Cambridge 
Isotope Laboratories, Inc. (Tewksbury, MA). Y76L TruB was generated in silico  
and energy-minimized using the GROMOS 43B1 force field [82] as implemented 
in Swiss-Pdb Viewer v4.0. [83] PyMOL v1.3 was used to generate high-resolution 
graphics of these structures. [84] 
Subcloning, overexpression, and purification of Y76L TruB  
The plasmid encoding Y76L TruB (pUL323) was created by introducing a 
point mutation into truB (from E. coli) in pΨ55 using the Stratagene QuickChange 
site-directed mutagenesis kit using the manufacturer’s protocols with the following 
primers: 5′-GACTCCGACAAAGGTCTCCGGGTCATTGCG-3′ (forward), and 5′-
CTGTCCAAGACGCGCAATGACCCGG-3′ (reverse); the sequence of the insert in 
pUL323 was verified by DNA sequencing. BLR(DE3) pLysS cells were transformed 
with pUL323 for the overexpression of Y76L TruB. Overexpressed Y76L TruB was 
purified over Ni-NTA resin (Qiagen) using the same protocol used for wild-type 
TruB. [64] Subsequently, Y76L TruB was polished over a POROS HQ anion 
exchange column (PE Biosystems) attached to a BioCAD SPRINT FPLC run by 
Perfusion Chromatography Workstation v3.01. Elution was achieved by 
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application of a gradient of potassium chloride (0.1–1.4 M) in 50 mM Tris•HCl 
buffer, pH 7.9; the enzyme generally eluted at 325–450 mM salt. Fractions bearing 
Y76L TruB were tested for RNase contamination, and the RNase-free fractions 
were pooled, concentrated, and stored at -20 °C in 50 mM HEPES buffer, pH 7.5, 
containing ammonium chloride (100 mM), EDTA (1 mM), and glycerol (10%,v/v). 
Digestion and MALDI-MS analysis of Y76L TruB 
Pepsin digestion 
Y76L TruB (50–100 µg) was incubated for 5 min at 94 °C to denature the 
protein, which was pelleted by centrifugation (18,000g, 5 min). A slurry (120 µL) of 
immobilized pepsin in aqueous trifluoroacetic acid (0.1%, v/v), pH 2.5, was then 
added to the pelleted protein. After incubation for 12 h at 37 °C, an aliquot (10 µl) 
of the digest was loaded on to a ZipTipC18 pipetter tip (Millipore, Bedford, MA); the 
bound peptides were washed (10 × 10 µl) with aqueous trifluoroacetic acid (TFA) 
(0.1%, v/v) and eluted with matrix solution (5 µl), which was 4-chloro-α-
cyanocinnamic acid (6.24 mg/ml) in 70% aqueous acetonitrile containing TFA 
(0.1%, v/v). The ZipTip eluate (1 µl) was spotted on a MALDI sample plate and air 
dried. Mass spectra were acquired using a Voyager DE-Pro MALDI-TOF 
instrument (PE Biosystems, Foster City, CA) with acquisition in positive reflectron 
mode with an extraction delay time of 200 ns and 400 laser shots per spectrum. 
Calibration was achieved using a 1:1:2 mixture of Bradykinin fragment 1-7 
(757.399 monoisotopic mass), fragment 18-39 of ACTH (2465.1989), and the 





Y76L TruB (50 µg) was heat-denatured and pelleted as described above. 
The pellet was suspended in 100 mM Tris buffer, pH 7.8, containing calcium 
chloride (10 mM), to which chymotrypsin (2 µg) was added followed by incubation 
for 12 h at 37 °C. An aliquot (10 μL) of the digestion mixture was desalted using 
ZipTipC18, and mass spectra were acquired as described above for the pepsin 
digestion. 
Analysis of Y76L TruB and [F5U]TSL reaction 
Y76L TruB (10 µM) was incubated at 37 °C with [F5U]TSL (50 µM) in 50 mM 
HEPES buffer, pH 7.5, containing ammonium chloride (100 mM), EDTA (1 mM), 
and DTT (5 mM) (hereafter, standard reaction buffer). Aliquots (30 µL) were 
withdrawn at 3 h and 6 h and quenched by mixing with 2x Laemmli buffer (30 µL). 
Following this, the sample was either heated for 5 min at 94 °C or loaded directly 
onto the gel (0.1% v/v, 10%, 10×10 cm), which was run (165 V, 80-90 min) and 
stained with Coomassie Blue to visualize protein bands. 
For HPLC analysis of the RNA, an aliquot (10 µL) of the reaction mixture 
was diluted into S1 nuclease digestion buffer (90 µL), which is 30 mM sodium 
acetate buffer, pH 4.6, containing sodium chloride (50 mM), zinc chloride (10 mM), 
and glycerol (5%, v/v). S1 nuclease (0.5 µL, 50 U) was added, and the mixture was 
incubated for 1 h at 37 °C and then at 94 °C for 5 min followed by cooling on ice 
for 5 min. Subsequently, a fresh aliquot of S1 nuclease (1 µL, 100 U) and alkaline 
phosphatase (3 µL, 3 U) were added, and the mixture was incubated for 3 h at     
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37 °C. The digestion mixture was then analyzed over an SB-C18 analytical column 
connected to Beckman Coulter System Gold HPLC (Indianapolis, IN) equipped 
with a Model 168 programmable diode array detector module. 
Inhibition of Y76L TruB by [F5U*]TSL 
Y76L TruB (10 µM) was either pre-incubated with [F5U*]TSL (20 µM) for 15 
min at 37 °C or was allowed to react directly with [F5U]TSL (50 µM) in standard 
reaction buffer (60 µL) at 37 °C. Aliquots (10 µL) of the reaction mixture were 
withdrawn at various times (0-240 min) and were immediately quenched by 
incubation in boiling water for 5 min followed by cooling on ice for 5 min. The aliquot 
was then diluted into S1 nuclease digestion buffer (90 µL), digested with S1 
nuclease, dephosphorylated with alkaline phosphatase, and analyzed by reverse 
phase HPLC as described above.  
Deuterium wash-in 
Deuterated standard reaction buffer was prepared by repeated 
lyophilization (3x) of the standard reaction buffer to dryness and redissolution in 
D2O (>99%). All exchangeable protons in [F5U]TSL were replaced with deuterium 
by three cycles of dissolution and lyophilization with deuterated buffer. [F5U]TSL 
(50 µM) in deuterated standard reaction buffer (146.5 µL) was incubated for 5 min 
at 37 °C before the reaction was started by the addition of Y76L TruB (10 µM, 3.5 
µl), which resulted in a final deuterium content of 96.6%. After 4 h at 37 °C, the 
reaction was heated to 94 °C for 5 min, cooled on ice for 5 min, centrifuged 
(18,000g, 5 min) and spun to pellet the protein, which was discarded. Residual 
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protein was extracted from the supernatant with 1:1 phenol:chloroform, and the 
RNA was precipitated with ethanol and air-dried. The RNA was redissolved in       
S1 nuclease digestion buffer (100 µL), and digested to nucleosides by the 
combination of S1 nuclease (2 × 5 µL with heat denaturation in between, 500 U) 
and alkaline phosphatase (5 µL, 5 U). After the complete digestion was confirmed 
by analytical HPLC, F5U* was isolated by preparative reverse phase HPLC over 
an ultrasphere•C18 column (5 µM, 10 × 250 mm; Beckman-Coulter, Fullerton, CA), 
eluting with a gradient of acetonitrile in water using the method described 
elsewhere [85] but with a flow rate of 3 mL/min; under these conditions, F5U* eluted 
at 4-4.5 min. The fractions containing F5U* were combined and concentrated to 
dryness in vacuo, and a part of the residue was dissolved in water (15 µL) and 
then diluted with a 1:1 (v/v) mixture of methanol and formic acid (135 µL). The F5U* 
was then analyzed by high resolution mass spectrometry in negative mode on a 
Thermo Finnigan (Bremen, Germany) Linear trap quadrupole Fourier transform 
(LTQ-FT) mass spectrometer equipped with a Triversa Nanomate (Ithaca, NY) 
direct infusion nano – electrospray ion (nESI) source. An unlabeled control reaction 
was run by incubating TruB (10 µM) with [F5U]TSL (50 µM) in standard reaction 
buffer (150 µL) followed by analysis as described above. Data was analyzed using 
Xcalibur v. 2.0 (Thermo Electron; Waltham, MA). For the labeled reaction 
(96.66%, D2O, the isotopic contributions from each element (2H, 13C, 15N, 18O etc.) 
in M+1 and M+2 peaks were calculated relative to the intensity of the monoisotopic 
peak, which was set to a value of 100%. The difference between the relative 
intensity value thus obtained for 2H and the relative intensity of the monoisotopic 
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peak from the unlabeled reaction was then adjusted by the isotopic composition of 
the labeled buffer (96.66%, D2O) to obtain the percentage of deuterium wash-in. 
Spectral simulations for a set percentage of deuterium incorporation were obtained 
using the embedded ‘isotope simulation’ tool in Xcalibur v. 2.0. This was 
achieved by manually defining the mole fractions of protium and deuterium in the 





In silico analysis 
An overlap of the cocrystal structure of wild-type TruB and [F5U]RNA [40] 
with that of in silico Y76L TruB [83, 84] showed a comparatively spacious active 
site for the variant, primarily due to the lack of steric hindrance associated with the 
phenyl ring of Tyr-76 (Figure 3.8 and 3.9). The energy-minimized structure for 
Y76L TruB shows the side chain of Leu-76 positioned perpendicular to the 
pyrimidine ring of F5U, in contrast to the more nearly parallel orientation of the Tyr-
76 phenyl ring in wild-type TruB (Figure 3.8). The effect of the Y76L mutation on 
the positioning of F5U in the active site could not be fully determined because of 
software limitations that allow energy minimization for the enzyme itself but not 
bound molecules, including the RNA substrate. [12, 13] The space-filling views of 
the active sites for Y76L and wild-type TruB (Figure 3.9) were compared to see if 
the conserved Asp may now have access to exchange freely with bulk solvent. 
Even though the RNA remained rigidly fixed, the active site definitely appears more 
accessible to solvent.  
Subcloning, overexpression and purification of Y76L TruB 
 To introduce the Y76L point mutation to N-terminally His6•tagged TruB, 
pUL323 was created from its parent plasmid pΨ55. Overexpressed Y76L TruB 
was purified to near homogeneity by nickel affinity chromatography followed by 
anion exchange chromatography. Subsequent storage of Y76L TruB under 




Figure 3.8: An in silico comparison of the active sites of TruB variants. A, 
Y76L TruB. B, wild-type TruB. The energy-minimized structure for Y76L 
TruB shows different positioning of Leu-76 and Tyr-76 with respect to F5U. 
[51] 





Figure 3.9: Space-filling view of the active site of TruB variants. A, Y76L 
TruB. B, Y76L TruB. Active site amino acids other than the conserved Asp-
48 and Tyr/Leu-76 are in green. The lower view is rotated 180° relative to 
the upper view. Extra space is introduced around the pyrimidine ring of 




Figure 3.10: SDS-PAGE analysis of the overexpression and purification of 
Y76L TruB. A, Overexpression of Y76L TruB. B, Fractions of purified Y76L 
TruB. MW, EZ-Run protein markers (Fisher Scientific; Waltham, MA). 
115 
 
activity within one week. This instability was successfully addressed by storage at 
–20 °C in in 50 mM HEPES buffer, pH 7.5, containing ammonium chloride (100 
mM), EDTA (1 mM), and glycerol (10%, v/v). Under these conditions, the stability 
of Y76L TruB improved, with <15% loss of activity after one month.  
MALDI-MS of Y76L TruB 
The sequence of Y76L TruB was verified by MALDI-TOF MS analysis after 
digestion with chymotrypsin (Figure 3.11) or pepsin (data not shown). When 
compared to the digest of wild-type TruB, the expected shift of 50 m/z was 
observed for the variant peptide containing Leu in place of Tyr-76. 
Reaction of Y76L TruB with [F5U]TSL 
Identity of the F5U product of the Y76L 
Y76L TruB (10 µM) was incubated with [F5U]TSL (10 µM) in standard 
reaction buffer for 3 h at 37 °C. The RNA sample from this reaction was digested 
to individual nucleosides and analyzed by reverse phase HPLC. A peak was 
observed with identical retention time to the major (ribo) product of F5U from the 
action of wild-type TruB (Figure 3.12). A co-injection of the S1 nuclease-digested 
RNA resulting from the action of wild-type and Y76L TruB on [F5U]TSL confirmed 




Figure 3.11: Partial mass spectra of the peptides from the chymotryptic 
digestion of Y76L (lower) and wild-type TruB (upper). A change in mass is 
observed for the peptide 69LLDSDKRX76 from wild-type TruB (X = Tyr, 
1009.52 m/zpred) versus Y76L TruB (X = Leu, 959.54 m/zpred; results from 










Figure 3.12: Partial HPLC trace of the products of F5U from the action of 
wild-type (blue) and Y76L (green) TruB. Co-injection results in a 
stoichiometric increase in the integration for the major product of F5U. *, 




To test whether the variant enzyme can form an adduct with [F5U]RNA, 
Y76L TruB (10 µM) was incubated with [F5U]TSL (50 µM) in standard reaction 
buffer for 3-6 h at 37 °C. Aliquots of this reaction were analyzed by SDS-PAGE. 
Similar to the behavior of wild-type TruB, [25] no adduct was observed with Y76L 
TruB even after 6 h of incubation with [F5U]TSL (Figure 3.13). 
Time course for the formation of [F5U*]TSL 
To see whether Y76L TruB can achieve multiple turnovers of [F5U]TSL like wild-
type TruB, [F5U]TSL (50 µM) was incubated with Y76L TruB (5-10 µM) in standard 
reaction buffer for 12 h at 37 °C. Aliquots (10 µL) of this reaction were withdrawn 
at regular time intervals, and the RNA was digested to individual nucleosides and 
analyzed by HPLC. Wild-type TruB (200 nM) completely turns over [F5U]TSL (20 
µM) within 3 h, [25] but Y76L TruB achieved only ~2.5 turnovers even after 12 h 
(Table 3.1). Also, the enzyme slowed considerably after the first turnover; it is 
~600-fold slower than the wild-type TruB. The observed decrease in the activity of 
Y76L TruB towards [F5U]TSL raises the question of whether the rate of the reaction 
is being limited by slow product dissociation. To address this issue, Y76L TruB (10 
µM) was incubated with [F5U*]TSL (20 µM) in standard reaction buffer for 15 min 
at 37 °C before the addition of [F5U]TSL (50 µM). The pre-incubation led to a ~16-




Figure 3.13: SDS-PAGE analysis (10% gel) of the reaction between Y76L 
TruB and [F5U]TSL. No adduct band was observed even after prolonged 






Y76L TruB, µM [F5U]TSL, µM time, h [F5U*]TSL, µM 
10 50 3 18 
10 50 6 21 
10 50 12 25 
5 50 3 10 
  
Table 3.1: Production of [F5U*]TSL observed for different ratios of Y76L 










5 7.22 ± 0.77 – 
10 8.26 ± 1.02 23.04 ± 0.07 
45 12.60 ± 0.97 25.55 ± 1.27 
90 14.72 ± 1.40 26.99 ± 1.34 
150 17.47 ± 2.98 28.78 ± 1.17 
240 19.08 ± 3.89 29.41 ± 0.46 
  
Table 3.2: [F5U*]TSL formed by Y76L TruB (10 µM) from [F5U]TSL (50 µM) 





Figure 3.14: Inhibition of Y76L TruB by [F5U*]TSL. A, Formation of 
[F5U*]TSL by Y76L TruB (10 µM) with (□) and without (●) pre-incubation 
with [F5U*]TSL (20 µM) prior to addition of [F5U]TSL (50 µM). B, The later 
phase of reaction with (□) and without (●) pre-incubation. The plotted 
values for the reaction with pre-incubation (□) are adjusted by subtraction 




Y76L TruB (10 µM) was incubated with [F5U]TSL (40 µM) in either unlabeled 
or deuterated standard reaction buffer for 4 h at 37 °C. A comparison of the product 
of F5U (F5U*pC)5 from the reaction run in labeled versus unlabeled buffer revealed 
that a low amount of deuterium wash-in occurred (Figure 3.15 and Table 3.3). The 
isotopic contribution from 2H can be clearly seen for the M+1 and M+2 peaks 
(Figure 3.16) with the contributions from 2H and 13C clearly resolved (insets). 
Based on these high-resolution spectra, 4.45% wash-in was calculated. Repetition 
of the wash-in experiments, however, showed a lower percentage (0.52% and 
0.92%) of deuterium incorporation into F5U*pC (Table 3.4). 
  
                                                
5 The product of F5U was isolated as a dinucleotide with cytidine on the 3′-end (F5U*pC). 






Figure 3.15: Comparative FT-MS of the purified dinucleotide F5U*pC. A, 
Natural abundance isotopic distribution. B, Observed isotopic distribution 
for the reaction in unlabeled buffer. C, Observed isotopic distribution for 




Figure 3.16: High resolution mass spectrum of [F5U*pC]-. The inserts 
show close-up views of the M+1 and M+2 ion clusters. The spectra for the 
dinucleotide obtained from the reaction run in unlabeled buffer (H2O) and 
deuterated buffer (D2O) are presented along with simulated spectra for 
natural abundance and for 5% non-exchangeable deuterium (5%D). A 
deuterium incorporation of 4.45% from the solvent was observed. *, 





Table 3.3: Mass spectral analysis (negative mode) of the dinucleotide 
product F5U*pC obtained from the action of Y76L TruB on [F5U]TSL 
conducted in unlabeled and labeled buffers. Bolded rows show the 






Table 3.4: Mass spectral analysis (negative mode) of the dinucleotide 
product F5U*pC for the successive trials of wash-in experiments. 





In silico analysis showed that the Y76L substitution results in a more open 
TruB active site that may provide greater access to solvent molecules and thus 
allow deuterium wash-in. A plasmid encoding Y76L TruB was generated and used 
to overexpress the variant enzyme. Purified Y76L TruB was stored under slightly 
modified conditions since activity was lost under the storage conditions used for 
wild-type TruB. [86]  
The initial characterization of Y76L TruB by Phannachet et al. did not 
include denaturing PAGE analysis to test if this variant forms an adduct when 
incubated with [F5U]TSL. As with wild-type TruB, no adduct was observed for Y76L 
TruB on SDS-PAGE gels, even after prolonged incubation with [F5U]TSL (Figure 
3.14). Also, reverse phase HPLC analysis of product nucleotides showed that 
Y76L TruB handles [F5U]TSL and forms a rearranged, hydrated product from F5U. 
However, in contrast to wild-type TruB, Y76L TruB forms a single product, which 
was confirmed as the major (ribo) product generated by the action of wild-type 
TruB (Figure 3.1). One explanation for the formation of a single product of F5U 
could be that the Tyr to Leu substitution induces a change in active site geometry 
that alters the relative positions of the F5U and conserved Asp. In this scenario, 
the conserved Asp may no longer be able to access the ribose ring from the 
“bottom” face to yield the arabino product of F5U. However, this hypothesis cannot 
be confirmed because a cocrystal structure of Y76L TruB with [F5U]TSL has not 
been reported, and the limitations of the in silico analysis [83, 84] do not allow 
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confidence that it can deliver definitive changes in the positioning of the active site 
groups. 
Y76L TruB catalyzes the reaction of F5U ~600 fold slower than does wild-
type TruB, and the first turnover occurs much faster (Table 3.1, Figure 3.14). This 
slow activity of Y76L TruB towards [F5U]TSL could be a case of product inhibition 
that is caused either by the slow dissociation of [F5U*]TSL from the enzyme after 
the initial turnover or a binding competition between [F5U*]TSL and [F5U]TSL. To 
answer this question, Y76L TruB was pre-incubated with [F5U*]TSL (1:2) in 
standard reaction buffer followed by assaying with [F5U]TSL. HPLC analysis of this 
reaction showed a ~16 fold reduction in the initial rates of formation of [F5U*]TSL 
(Figure 3.14, panel B), a result that indicates competition between the [F5U]TSL 
and its product. 
Deuterium wash-in 
High resolution mass spectrometry 
A mass spectrum consists of a sum of signals from species of various 
possible isotopologues (for example, 13C, 15N, 2H, etc.). The isotopic distribution 
for each singly charged molecular species consists of peaks spaced 1 m/z apart. 
The monoisotopic peak, which is the isotopologue with only the most abundant 
isotope of each element, uniquely reflects elemental composition as every other 
peak in the mass spectrum represents contributions from different combinations of 
less abundant isotopes of the constituent elements. For example, a species of the 
monoisotopic mass +2 m/z (M+2) can represent an isotopic combination of two 
130 
 
13C, two 15N, one 13C and one 15N, two 2H, etc. Such elemental combinations, 
however, differ from each other by a few mDa, and a mass spectrometer of 
sufficiently high resolution can distinguish the contribution from each element. In 
the current study, the contribution from 2H is at issue.  
Deuterium incorporation into the [F5U*]TSL 
Deuterium wash-in was anticipated because the in silico analysis—despite 
its limitations—clearly indicated a more open active site in Y76L TruB. The 
observed 4.45 % deuterium incorporation bore out this prediction (Figure 3.16; 
Table 3.3). Replicates were run to confirm the low level of wash-in, and they 
showed even lower levels (0.52% and 0.92%) of deuterium incorporation into the 
product of F5U. The significance of these minute levels of wash-in must be viewed 
with skepticism. Although substantial wash-in would have been informative, its 
absence is not because the removed proton may remain occluded from the solvent 
even in the Y76L variant. A more definitive approach to test the glycal mechanism 
is to seek for a primary kinetic isotope effect by comparing the reaction rates of 
substrates prepared with [2′-2H]U with those of unlabeled substrates, which is 









DEUTERIUM KINETIC ISOTOPE EFFECT STUDIES TO PROBE THE 
GLYCAL MECHANISM 
 
Pseudouridine synthases (Ψ synthases) convert uridine (U) to its                   
C-glycoside isomer pseudouridine (Ψ). They are classified into six different families 
that share no statistically significant global sequence similarity but have identical 
folds and are thus thought to have resulted from divergent evolution. [18] An active 
site aspartic acid residue conserved among all Ψ synthases (hereafter, the 
‘conserved Asp’) is absolutely essential for the activity. [64] Ψ synthases TruA and 
RluA get irreversibly inhibited by 5-fluorouridine-containing RNA ([F5U]RNA), [29, 
30, 36] which led to the proposal of the ‘Michael mechanism’, in which the 
conserved Asp forms a Michael adduct with C6 of the pyrimidine ring (Figure 4.1) 
[36].The alternative ‘acylal mechanism’ involves the conserved Asp as a 
nucleophile, but with attack at C1′ of the ribose ring to form an acylal intermediate 
(Figure 4.2) [36]  
Ψ synthases differ in their action towards [F5U]RNA. While TruA and RluA get 







Figure 4.1: The ‘Michael mechanism’ for Ψ synthases. The conserved Asp 
makes a nucleophilic attack at C6 to form a Michael adduct. N-glycosidic 
bond cleavage followed by a net 180° rotation of the adducted pyrimidine 
repositions it for the subsequent C-glycoside formation. Expulsion of the 






Figure 4.2: The ‘acylal mechanism’ for Ψ formation. This mechanism 
begins with the conserved Asp making a nucleophilic attack at C1′ of the 
ribose ring, either through a concerted or step-wise process, thereby 
displacing the pyrimidine ring. The uracilate anion rotates to reposition 
itself to effect C-glycoside formation. The expelled Asp deprotonates C5 




PAGE analysis, [30, 36] E. coli TruB does not get inhibited and turns over 
[F5U]TSL6 into two rearranged and hydrated products (hereafter, the ‘major’ and 
‘minor’ products of F5U). [25] NMR experiments by Miracco and Mueller showed 
that TruB and RluA form the same products of F5U which differ in the sugar rather 
than the pyrimidine ring: the major product of F5U was the ribo isomer previously 
found in the cocrystal structure of TruB and [F5U]RNA [40] whereas the minor 
product was the arabino isomer (Figure 3.1). [43]  
The change in configuration at C2′ requires epimerization during formation 
of the minor versus the major product. C2′ must be deprotonated to form a glycal 
intermediate followed by reprotonation from the “bottom” face. (Figure 4.3) [43] 
The deprotonation of C2′ can be achieved either by the conserved Asp or O2 of the 
pyrimidine ring. [87] However, the conserved Asp is the only acid/base group 
positioned near enough to C2′ to donate a proton to its “bottom” face—an 
observation that strongly argues against the Michael mechanism since the 
conserved Asp is tied up as an ester.  
The arabino product of F5U is still consistent with the acylal mechanism 
(Figure 3.2). [43] The diminished nucleophilicity of the anion of 5-fluorouracil 
results in an increased lifetime for the acylal intermediate and the oxocarbenium 
species with which it is in equilibrium. [43] The increased acidity of C2′ in the 
oxocarbenium species makes its deprotonation by the detached conserved Asp 
                                                
6 Ψ synthase TruB was previously shown to handle stem-loop substrate (TSL) as well as the 
full length tRNA substrate. [29] The same is true for RluA with ASL. [30]  
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easier, and reprotonation of C2′ from the opposite face results in the arabino 
product of F5U (Figure 3.2). 
A glycal intermediate along the Ψ synthase reaction with U opens up a new 
mechanistic possibility, the ‘glycal mechanism’ (Figure 4.3), which can easily 
explain both the major and minor products of F5U (Figure 4.4) and is precedented 
by uridine phosphorylase [87]. With normal substrate (containing U), the 
mechanism proceeds through the deprotonation of C2′ either by the conserved 
Asp or by the O2 of the pyrimidine ring to eliminate the anion of uracil and form the 
glycal intermediate. Following rotation of the detached pyrimidine ring and C-
glycoside formation with reprotonation of C2′, deprotonation of C5 by the 
conserved Asp generates Ψ.  
If the conserved Asp deprotonates C2′, the removed proton resides 
temporarily on the Asp, where it may be prone to exchange with the solvent protons 
and therefore provide strong evidence for a glycal intermediate (Figure 3.5). [79, 
80] With TruB and RluA, deuterium wash-in studies conclusively ruled out such 
exchange with both U- and F5U-containing RNA substrates. Wash-in experiments 
with the carefully chosen Y76L TruB that has a more open active site resulted in a 
very low (<4.5%) deuterium incorporation into the products of F5U (Chapter 3). The 
lack of wash-in during the formation of minor product of F5U (25-33% of total 
products) clearly shows that the proton removed from C2′ is rigorously occluded 
from bulk solvent on the time scale of reaction. The same scenario for the 
conversion of U to Ψ or F5U to the major product—neither of which requires 





Figure 4.3: The proposed ‘glycal mechanism’ for Ψ formation. The 
conserved Asp initiates the reaction by deprotonating C2′ that leads to a 
glycal intermediate. After the C-glycoside rearrangement, C2′ is 




Figure 4.4: The glycal mechanism with [F5U]RNA. Following the 
deprotonation of C2′ by the conserved Asp that leads to the glycal 
intermediate formation, reprotonation from the bottom face of the C2′ 
would result in the observed arabino product of F5U. 
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mechanism. A more direct and definitive approach than wash-in was sought to 
obtain evidence for the glycal mechanism.  
Deuterium kinetic isotope effect   
If the Ψ synthase reaction proceeds through a glycal intermediate, 
deprotonation or reprotonation of C2′ (or both) may be partially rate-limiting. In this 
case, substituting the proton on C2′ of U and F5U with deuterium (Figure 4.5) 
should display a primary, deuterium kinetic isotope effect (2KIE), [88] manifested 
by a reduction in rate. To test this scenario, stem-loop substrates for TruB and 
RluA were prepared with [2ʹ-2H]U, and their rates were compared with unlabeled 
substrates.  
 




Figure 4.5: The glycal mechanism with [2′-2H]U containing substrate. If 
either deprotonation or reprotonation of C2′ is partially rate limiting, a 




All standard chemicals, unless specified were purchased from Fisher 
Scientific (Pittsburgh, PA) or Sigma Aldrich (Milwaukee, WI). [2′-2H]ribose was 
purchased from Omicron Biochemicals, Inc. (South Bend, IN). Restriction 
endonucleases NdeI and BamHI and thermostable inorganic pyrophosphatase 
were purchased from New England BioLabs (Ipswich, MA). Phosphoenolpyruvate 
(PEP) was purchased from Chem-Impex International (Wood Dale, IL). Pyruvate 
kinase/lactate dehydrogenase enzyme cocktail, pyruvate kinase II from rabbit 
muscle, ribose 5-phosphate barium salt (R5P•Ba), Dowex-50 (H+ form), and Norit® 
and Darco G-60 activated charcoal were obtained from Sigma Aldrich (Milwaukee, 
WI). The Dowex-50 (H+ form) was cleaned by the method of Cleland. [89] Prior to 
use, the activated charcoal (2 g) was mixed with 0.01 N HCl (30 mL); the mixture 
was centrifuged (8000g, 15min), and the supernatant was discarded. Yeast 
myokinase was purchased from CalBiochem (Billerica, MA). Amicon DIAFLO 
ultrafiltration units were purchased from Millipore Corporation (Bedford, MA). Bond 
Elut C8 solid phase extraction cartridges (5 g, 20 mL) were obtained from Agilent 
(Santa Clara, CA). DNA oligonucleotides were purchased from Integrated DNA 
Technologies (Coralville, IA). Ribonucleotide triphosphates (rNTPs) were 
purchased from Promega (Madison, WI), and T7 RNA polymerase was purchased 
from Epicentre biotechnologies (Madison, WI). Stop RNase Inhibitor RX was 
purchased from 5 PRIME, Inc. (Gaithersburg, MD), and TURBO DNase was 
purchased from Life Technologies (Carlsbad, CA). Phosphoribosyl pyrophosphate 
(PRPP) was freshly isolated by the method of Gross et al. [90] All coupled 
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enzymatic activity assays were performed with a DU® 800 Series UV/Vis 
spectrophotometer (Beckman Coulter; Pasadena, CA) equipped with a six cell 
transporter and a Peltier temperature controller. NMR spectra were acquired using 
a 400-MR spectrometer equipped with a 5 mm direct HX z-PFG broadband probe 
(Varian Inc., Palo Alto, CA) 
Enzymatic synthesis of [2′-2H]UTP 
Subcloning, overexpression and purification 
Ribokinase. The plasmid (pET22-HT) bearing the ribokinase gene (rbsK) 
was generously provided by J. Williamson, [91, 92] but it did not properly express 
ribokinase. DNA sequencing revealed an overhang after the stop codon and an 
inverted duplication at the 5′-end. To rectify these errors, NdeI and BamHI 
restriction sites were introduced at the 5′- and 3′-ends of rbsK, respectively, by 
PCR amplification with the following primers: 5′-
GCTCCTCATATGCAAAACGCAGGCAGCC-3′ (forward), and 5′-
GCTTCGGGATCCTCACCTCTGCCTGT-3′ (reverse). The PCR product was 
digested with both NdeI and BamHI and ligated into pET-15b (Novagen; Billerica, 
MA) opened with the same restriction enzymes to create pUL600 for the 
expression of ribokinase with N-terminal His6•tag. The proper insertion of rbsK into 
the plasmid was verified by DNA sequencing. BLR(DE3) pLysS was transformed 
with pUL600, and ribokinase was overexpressed and purified over Ni-NTA resin 
(QIAGEN) according to a published protocol. [64] Purified fractions of ribokinase 
were tested for activity, pooled, concentrated, and dialyzed overnight into the final 
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storage buffer, which is 50 mM phosphate buffer, pH 7.5, containing sodium 
chloride (150 mM) and glycerol (50%, v/v), for storage at -20 °C until needed. 
PRPP synthetase and uracil phosphoribosyl transferase (UPRTase). The 
plasmids encoding Salmonella typhimirium PRPP synthetase and E. coli UPRTase 
were generously provided by S. Van Lanen. [93] Both plasmids were based on 
pET-30a (+) (Novagen) so that the encoded proteins are expressed with an N-
terminal His6•tag. Following transformation of BLR(DE3) pLysS cells with these 
plasmids, PRPP synthetase and UPRTase were overexpressed and purified over 
Ni•NTA resin. Column fractions were assayed for activity, and enzyme-bearing 
fractions were pooled, concentrated, and stored -20 °C in 50 mM sodium 
phosphate buffer, pH 7.5, containing sodium chloride (300 mM) and glycerol    
(50% v/v). 
Ribokinase assay 
The activity of ribokinase (Figure 4.6) was determined using an assay 
coupled to the consumption of NADH. [90, 92] The reaction mixture (1 mL), was 
50 mM Tris•HCl buffer, pH 7.5, containing D-ribose (50 mM), potassium chloride 
(100 mM), magnesium chloride (10 mM), NADH (0.2 mM), ATP (3 mM), PEP (1 
mM), pyruvate kinase (3.3 µL, 2 U), and lactate dehydrogenase (3.3 µL, 2 U). The 
cuvette containing the reaction mixture was inserted into the spectrophotometer 
and held at 25 °C until a steady base line was observed at 340 nm. Ribokinase 
(<1 µL, 1 µg) was then added, and the contents of the cuvette were mixed by 
inversion. The change in A340 was monitored with time, and the rate of change and 
ε340 of NADH (6220 M




R5P•Ba (100 mM, 1mL) was exchanged into its sodium form (R5P•Na) by 
passing it through column (2 × 1 cm) of Dowex-50 (Na+ form). R5P•Na was 
quantitated by dephosphorylating it with alkaline phosphatase and measuring the 
concentration of the released inorganic phosphate by the Ames test. [94] 
PRPP synthetase assay 
The assay of PRPP activity (Figure 4.6) also rested on coupling to NADH 
consumption. [90, 95] The assay mixture (1 mL) was 100 mM sodium phosphate 
buffer, pH 7.6, containing R5P•Na (5 mM), magnesium chloride (7 mM), NADH 
(0.2 mM), ATP (3 mM), PEP (1 mM), pyruvate kinase (3.3 µL, 2 U), myokinase (4 
µL, 4 U), and lactate dehydrogenase (3.3 µL, 2 U). After a steady baseline was 
observed at 340 nm, PRPP synthetase (<1 µL, 1 µg) was added, and the contents 
of the cuvette were mixed by inversion. The change in A340 was monitored with 
time, and the rate of change and ε340 of NADH (6220 M
-1•cm-1) was used to 
calculate the activity (Table 4.1) 
UPRTase assay 
The assay for UPRT activity (Figure 4.6) is based the change in                 
Δε271 = 2763 M
-1•cm-1 for uracil and UMP (greater ε271). [91] The assay mixture       
(1 mL) was 50 mM Tris•HCl buffer, pH 7.5, containing magnesium chloride (5 mM), 
PRPP (1.5 mM), and uracil (0.1 mM). After a steady baseline was observed at 271 
nm, UPRTase (<1 µL, 1 µg) was added and ΔA271 was monitored.  







Figure 4.6: Schemes of the activity assays for the overexpressed 
enzymes. A, Ribokinase. B, PRPP synthetase. C, UPRTase. MK, 
myokinase; PK, pyruvate kinase; LDH, lactate dehydrogenase. 
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Synthesis of [2′-2H]uridine triphosphate 
The published enzymatic synthesis of [2′-2H]UTP [91, 92] was adapted to a 
smaller scale (400 µmol). In a 50 ml tube, 2′-[2H]D-Ribose (60.7 mg, 400 µmol) and 
uracil (44.8 mg, 400 µmol) were dissolved in synthesis buffer (50 mL), which is 50 
mM potassium phosphate buffer, pH 7.5, containing DTT (20 mM), kanamycin (0.1 
mM), ATP (0.5 mM), ampicillin (5 mM), magnesium chloride (10 mM), and PEP 
(40 mM). The synthesis was initiated by the addition of ribokinase (50 U), PRPP 
synthetase (50 U), UPRTase (2 U), nucleoside monophosphate kinase (2 U), 
myokinase (37.5 U), and pyruvate kinase (75 U). [96] The reaction was monitored 
both by 31P NMR and an assay of pyruvate formation. [91, 92] After 108 h, no 
further increase in the amount of 2′-[2H]UTP was detected by 31P NMR, and the 
reaction was judged to be essentially complete (>90%) by pyruvate production. 
The reaction mixture was filtered through an Amicon DIAFLO YM-10 membrane 
(10,000 MWCO) to remove enzymes, and activated charcoal (2 g) was added to 
the reaction mixture (~48 mL) to adsorb UMP. After nutation for 15 min at 4 °C, the 
charcoal was pelleted by centrifugation (8000g, 15 min). After ensuring that the 
bulk of [2′-2H]UTP (and ATP) was adsorbed to charcoal by measuring the 
absorbance of supernatant at A260, the supernatant was discarded. The charcoal 
was washed successively with ice-cold water (20 mL) and aqueous ethanol (20 
mL; 2.5%, v/v) containing ammonium hydroxide (0.5%, v/v). Finally, the charcoal-
bound [2′-2H]UTP along with other “sticky” reaction components (primarily PEP 
and ATP) were eluted twice with aqueous ethanol (30 mL; 50% v/v) containing 
ammonium hydroxide (0.5% v/v). [97]. The ethanolic elutions (60 mL) containing 
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2′-[2H]UTP were combined and filtered through a Steriflip® vacuum filter unit to 
remove residual charcoal. The pH was adjusted to 6.5 using acetic acid (1 M), and 
the solution was evaporated to dryness in vacuo, which yielded [2′-2H]UTP as 
yellowish white powder (247 µmol, 69% yield).  
To remove PEP and ATP that co-eluted with [2′-2H]UTP, the yellowish white 
powder was redissolved in 5 mM triethylammonium acetate buffer (1 mL), pH 7.0, 
and loaded onto a Bond Elut C8 SPE cartridge pre-equilibrated with the same 
buffer: elution was achieved with a step gradient of aqueous acetonitrile (0-50%, 
v/v in 10% steps). 2′-[2H]UTP eluted between 0-2.5% acetonitrile. The fractions 
containing 2′-[2H]UTP were detected by the characteristic absorbance of uridine at 
260 nm. These fractions were combined, and reduced in volume in vacuo using a 
rotary evaporator. Triethylammonium acetate was removed by the repeated 
addition and removal of water and isopropanol in vacuo with maintenance of pH 
~8.0 by the addition of aqueous sodium hydroxide (1 M). The [2′-2H]UTP was 
recovered as a white powder and stored at -80 °C (165 µmol, 46% yield). 
1H NMR (400 MHz; D2O) δ: 7.95 (H6, 1H, doublet, J = 8.4 Hz), 5.95 (H1′/H6, 
2H, multiplet), 4.31 (H3′, 1H, doublet, J = 5.0 Hz), 4.23 (H4′/H5′/H5′′, 3H, broad 
multiplet). 
31P NMR (162 MHz; D2O; 1H) d: –5.97 Hz (α), –9.98 Hz (γ), –21.20 Hz (β). 
In vitro transcription of RNA substrates 
Unlabeled TSL. The partially double-stranded DNA template was prepared 
using commercially obtained oligonucleotides that had the following sequence: 5′-
ATTATGCTGAGTGATATCGACACAAGCTAGGTGTC-3′ (where underlining 
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denotes the template sequence for TSL) and 5′-TAATACGACTCACTATAGC-3′. 
The template was annealed by incubating the strands together (50 mM each in a 
volume of 100 µL) for 5 min at 65 °C followed by cooling on ice for 5 min. This 
template was added to the transcription mixture (10 mL), which is 40 mM Tris•HCl 
buffer, pH 8.1, containing rNTPs (4 mM each), GMP (8 mM), magnesium chloride 
(25 mM), spermidine (1 mM), DTT (5 mM), Triton X-100 (0.01 %, v/v), Prime 
RNase Inhibitor (10 µL, 10 U), and inorganic pyrophosphatase (5 µL, 5 U). The in 
vitro transcription reaction was initiated by adding T7 RNA polymerase (25 µL, 
25000 U) and incubated for 9 h at 37 °C. [64] Urea-PAGE analysis was used to 
monitor the reaction progress. Periodically, an aliquot (3 µL) of the reaction mixture 
was withdrawn and diluted with water (10 µL final volume); 2x RNA loading dye 
(10 µL) was added, and the sample was then heated for 5 min at 94 °C, cooled on 
ice for 5 min, and loaded on to a urea-PAGE gel (15%, 7M urea). The transcription 
products were visualized with SYBR® Gold nucleic acid stain.  
After analysis showed no further accumulation of TSL, TURBO DNase (5 
µL, 10 U) was added to the transcription reaction, which was incubated for an 
additional 15 min at 37 °C. Proteins were extracted from the reaction mixture with 
1:1 phenol:chloroform. The crude RNA in the collected aqueous phase was 
precipitated with ethanol and pelleted by centrifugation (8000g, 30 min). The 
pelleted RNA was washed with aqueous ethanol (70%, v/v), air dried, and 
dissolved in 10 mM Tris•HCl buffer, pH 7.5, containing EDTA (1 mM).  
The transcript of interest (18-mer) was purified from the crude mixture by 
urea-PAGE electrophoresis (15%, 7M urea; 15 cm × 15 cm). The crude transcript 
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(1 mL) was mixed with 2x RNA dye (1 mL), heated for 5 min at 94 °C, cooled on 
ice for 5 min, and loaded onto the gel. After being developed at 165 V for 6 h, the 
gel was removed, and the band of interest was located by UV-shadowing. RNA 
was extracted from the excised band either by electroelution using an Elutrap 
electrophoresis unit (GE Healthcare; Pittsburgh, PA) run at 200 V for 3 h, or by the 
crush and soak method. [98] RNA was ethanol-precipitated, pelleted by 
centrifugation (8000g, 30 min), and redissolved in RNase free water. Purified TSL 
was divided into aliquots and stored at -20 °C.  
Labeled TSL. The labeled transcript was prepared identically to the 
unlabeled transcript, except that [2′-2H]UTP (4 mM) was substituted for UTP. 
ASL. The in vitro transcription of ASL with UTP and [2′-2H]UTP was identical 
to the synthesis of TSL except for the template, which was composed of 5′-
GCGGATTTTCAATCCGCTATAGTGAGTCGTATTA-3′ (underlining indicates the 
complement to ASL) and 5′-TAATACGACTCACTATAGC-3′. 
Digestion of transcripts and MALDI-MS 
An aliquot of the RNA oligonucleotide (10 µL, 80-100 µM) was diluted into 
RNase-free water (40 µL) to which RNase T1 (2 µL, 200 U) was added. After 
incubation for 1 h at 37 °C, alkaline phosphatase (5 µL, 5 U) was added to the 
digestion mixture, which was incubated for an additional 3 h at 37 °C. An aliquot 
(3 µL) of the digest was mixed with 3-HPA matrix solution (3 µL), which was 3-
hydroxypicolinic acid (3-HPA; Fluka, Milwaukee, WI; 10 mg/ml) in 50% aqueous 
acetonitrile. The sample was spotted on a MALDI plate, air dried, and analyzed on 
a Voyager DE-Pro MALDI-TOF instrument or an API 4700 MALDI-TOF Mass 
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spectrophotometer (PE Biosystems, Foster City, CA). Spectra were acquired and 
analyzed as described in Chapters 2 and 3.  
Kinetic assays  
The enzymes TruB and RluA were overexpressed, purified, and assayed 
using published protocols. [30, 64] For TruB, the standard reaction buffer was 50 
mM HEPES buffer, pH 7.5, containing ammonium chloride (100 mM), EDTA (1 
mM), and DTT (5 mM). [64] The reaction mixtures (400-2600 μL) were standard 
reaction buffer containing TSL (1-10 µM). After pre-incubation for 3 min at 37 °C, 
reactions were initiated by the addition of a small volume (<2 µL) of TruB (to 10 
nM). Aliquots (75-650 μL) were removed at various time intervals and quenched 
into pre-heated (100 °C) tube containing 10x S1 nuclease digestion buffer (1/10th 
the volume of aliquot), which is 300 mM sodium acetate buffer, pH 4.6, containing 
sodium chloride (500 mM), zinc chloride (100 mM), and glycerol (50%, v/v). After 
another 5 min in a boiling water bath, the tubes were cooled on ice for 5 min. S1 
nuclease (0.5 µL, 50 U) was added, and the mixture was incubated for 1 h at 37 
°C; the digest was then incubated for 5 min at 94 °C followed by incubation on ice 
for 5 min. Another aliquot of S1 nuclease (1 µL, 100 U) and alkaline phosphatase 
(3 µL, 3 U) were added, and the mixture was incubated for 3 h at 37 °C. The digest 
was then passed through a Corning Costar spin filter (0.22 µm), and analyzed 
over an SB-C18 analytical column connected to Beckman Coulter System Gold 
HPLC (Indianapolis, IN) equipped with a Model 168 programmable diode array 
detector module.  
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For RluA, the previously reported assay procedure [30] was modified 
because, unlike commercially–obtained ASLU (a 17-mer), the in vitro transcribed 
ASLU (an 18-mer) was not readily separable from ASLΨ. To quantify Ψ, the 18-mer 
ASL was digested to its component nucleosides and analyzed by HPLC. The 
assay mixtures (450-2400 μL) were standard reaction buffer containing ASL (1-10 
µM). After pre-incubation for 3 min at 37 °C, reactions were initiated by the addition 
of a small volume (<2 µL) of RluA (to 10 nM). Aliquots (100-600 μL) were removed 







Enzymes for the synthesis of [2′-2H]UTP 
The plasmid encoding ribokinase (pET-22HT) showed poor levels of 
overexpression, and the activity of the overexpressed enzyme was low. DNA 
sequencing revealed insertions at both the ends of rbsK. To rectify these errors, 
NdeI and BamHI restriction sites were introduced on to the 5′- and 3′-ends of rbsK 
by PCR. This allowed both the restoration of the native gene by eliminating the 
insertions and a means to install rbsK in pET-15b. Use of this recombinant plasmid 
(pUL600) resulted in improved levels of expression for ribokinase (Figure 4.7). 
PRPP synthetase and UPRTase were expressed without incident. Assays 
revealed that all three enzymes had specific activities comparable to literature 
values (Table 4.1).  
Synthesis of [2′-2H]UTP 
Because [2′-2H]UTP is commercially unavailable, it was synthesized by the 
enzymatic condensation of [2′-2H]D-ribose and uracil (Figure 4.9) according to the 
method of Williamson. [91, 92] The first step of this one pot synthesis involves 
phosphorylation of [2′-2H]D-ribose by ribokinase. PRPP synthetase then converts 
[2′-2H]D-ribose-5-phosphate into [2′-2H]PRPP which is converted into [2′-2H]UMP 
by UPRTase. [2′-2H]UDP results from phosphorylation at the expense of ATP by 
nucleoside monophosphate kinase, following which [2′-2H]UTP is generated by 





Figure 4.7: Ribokinase overexpression as monitored by SDS-PAGE. A, 
With pET22-HT. B, With pUL600. MW, EZ-Run protein markers (Fisher 





Figure 4.8: Purification of enzymes for the synthesis of UMP as monitored 
by SDS-PAGE. A, Ribokinase. B, PRPP synthetase. C, UPRTase. NS, 
supernatant from nutation of cell lysate with Ni-NTA resin; L, flow through 
from loading the Ni-NTA resin into a column (0.7 × 4.0 cm); W1-3, washes 
(4 mL) with 50 mM sodium phosphate buffer, pH 8.0, containing sodium 
chloride (300 mM) and imidazole (20 mM); E1-2, fractions (4 mL) from 
elution with 50 mM sodium phosphate buffer, pH 8.0, containing sodium 
chloride (300 mM) and imidazole (250 mM); MW, EZ-Run protein markers 















reportedc specific activity  
µmol•min-1•mg-1 
total activity  
µmol•min-1 
ribokinase 0.2 ± 0.1a 
  36.4 ± 11.1 
22 ± 12 
 
99.9 ± 12.8b 6300 ± 150 
PRPP 
synthetase 
9.1 ± 1.3 11.4 ± 0.8 122 ± 16 
UPRTase 7.04 ± 0.65 14.8 ± 2.0 371 ± 39 
Table 4.1: Specific activities for ribokinase, PRPP synthetase, and 
UPRTase. 
 
aOverexpressed from pET-22HT. 
bOverexpressed from pUL600. 
cFrom reference 95 
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The overall synthesis minimally requires four equivalents of ATP, which was 
continuously generated in situ at the expense of PEP using pyruvate kinase and 
myokinase. To avoid buildup of ADP, the activity of myokinase was half that of 
pyruvate kinase.  
After the synthesis of [2′-2H]UTP was complete as judged by 31P NMR and 
pyruvate assay, purification was achieved in three steps. The enzymes used in the 
synthesis were removed by ultrafiltration. More than 90% of PEP, inorganic 
phosphate, and pyruvate in the reaction mixture were removed by the adsorption 
of [2′-2H]UTP and ATP onto charcoal, rinsing, and elution in aqueous ethanol. The 
[2′-2H]UTP was freed of contaminating ATP and PEP by solid phase extraction 
over a Bond Elut C8 SPE cartridge. [2′-2H]UTP (167 µmol, 46% yield) was obtained 






Figure 4.9: Enzymatic synthesis scheme for [2′-2H]UTP. ATP is generated 
in situ at the expense of PEP by pyruvate kinase and myokinase. 1, 
ribokinase; 2, PRPP synthetase; 3, UPRTase; 4, nucleoside 






Figure 4.10: 31P NMR spectrum of the purified [2′-2H]UTP showing the 






Figure 4.11: 1H NMR spectrum of purified [2′-2H]UTP. The “absence” of H2′ 







Figure 4.12: Comparison of the 1H NMR spectra of [2′-2H]UTP and 





In vitro transcription 
Unlabeled and labeled stem-loop RNA substrates for TruB and RluA were 
prepared by run-off in vitro transcription using T7 RNA polymerase. The template 
and rNTP concentrations and time were optimized because transcription efficiency 
is highly sensitive to them depending on the length of the RNA being transcribed. 
[99] The transcription of these short stem-loops required a higher concentration of 
DNA template (0.5 µM) and a longer incubation (9 h) when compared to the 
transcription of full length tRNA. [64] 
TSL. The original S. cerevisiae T-arm stem-loop tRNAPhe (TSL) substrate is 
a 17-mer that starts with a 5′-Cytidine. For efficient transcription, T7 RNA 
polymerase requires G as the initial nucleotide. Therefore, two TSL transcripts of 
lengths 18 (5′-G added to canonical TSL) and a 19-mer (5′-GG added) were tested 
for in vitro transcription and obtained in comparable yields (9 µmol 18-mer versus 
11 µmol 19-mer). When these transcripts (5 µM) were incubated with E. coli TruB 
(0.5 µM) in standard reaction buffer for 1 h at 58 °C, analysis of the digested 
nucleosides by reverse phase HPLC showed complete conversion for both 
transcripts, showing their competence as substrates. In aliquots withdrawn after 1 
min, the 18-mer (64.5%) showed greater conversion of U to Ψ than the 19-mer 
(52.0%), so the 18-mer RNA was chosen for large-scale transcription (10 mL). 
Once trials determined optimal in vitro transcription conditions, UTP and [2′-
2H]UTP were used in separate transcription reactions to generate unlabeled and 
labeled 18-mer TSL (Figure 4.13), which will hereafter be termed TSL for simplicity. 
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ASL. The anticodon-stem-loop from E. coli tRNAPhe (ASL) starts with a 
string of four Gs (Figure 4.14, panel A), which in principle eliminates the need to 
alter the 5′-end. However, small scale transcription revealed in a “ladder” of 
transcription products rather than a single one (Figure 4.14, panel C). Literature 
review [100, 101] revealed that T7 RNA polymerase undergoes “slippage” when 
transcribing RNA containing a stretch of three or more Gs, which is the case with 
ASL. This issue was addressed by designing a DNA template that would instead 
transcribe ASL with a reversed C-G base pair at the second position (Figure 4.14, 
panel B and C). This change resulted in a single transcription product. UTP and 
[2′-2H]UTP were used in separate large scale transcription reactions to afford 
labeled and unlabeled variant ASL, which will hereafter be termed ASL for 
simplicity (Figure 4.14). 
Sequence verification of transcripts 
The sequences of unlabeled and labeled TSL and ASL transcripts were 
verified by digestion with RNase T1 and analysis by MALDI-TOF mass 
spectroscopy. The digestion products containing [2′-2H]U showed a corresponding 
increase in the m/z value when compared to their unlabeled counterparts (Figure 







Figure 4.13: In vitro transcription results for TSL. A, Transcribed TSL (18-
mer). B, Urea-PAGE (15%, 7M urea) analysis of the crude in vitro 







Figure 4.14: In vitro transcription of ASL. A, Canonical ASL used in 
previous studies. [4] B, In vitro transcribed ASL (the arrow denotes the 
reversed base pair). C, Urea-PAGE (15%, 7M urea) analysis of the in vitro 
transcription of canonical ASL. D, Urea-PAGE (15%, 7M urea) analysis of 
the in vitro transcription of the variant ASL. E, Urea-PAGE (15%, 7M urea) 









Figure 4.15: Partial MALDI-TOF mass spectra for the RNase T1 digests of 
unlabeled (lower traces) and labeled (upper traces) TSL. A, CUG (895.16 
m/zpred). B, AUCCACAG (2492.40 m/zpred). C, UU55CG (1201.19 m/zpred). D, 







Figure 4.16: Partial MALDI-TOF mass spectra for the RNase T1 digests of 
unlabeled (lower traces) and labeled (upper traces) ASL. A, AU32UG 




TruB was assayed under conditions used previously. [64] The efficacy of 
the quench methodology was verified by analyzing time points for each assay 
immediately after addition of TruB to initiate the reaction. Because intact TSLU did 
not separate from intact TSLΨ, the product RNA was digested to individual 
nucleosides to quantify Ψ formation. The assays for the labeled and unlabeled 
substrates were performed at variable substrate concentrations as described in 
the Experimental section. The data was then fit to Briggs-Haldane equation (Figure 
4.17) to determine the kcat and Km values, which revealed significant 2KIEs (Table 
4.2) on both Vmax (2Vmax = 2.54) and Km (2(Vmax/Km) = 3.58). 
The assay for RluA was similar to that of TruB. The reaction quench 
methodology and the reverse phase HPLC-based quantification of ASLΨ were 
different from those previously reported [30] because the in vitro transcribed ASLU 
failed to separate from the intact ASLΨ. The assays for the labeled and unlabeled 
substrates were performed at different substrate concentrations and the initial 
velocity data was then fit to the Briggs-Haldane equation (Figure 4.18). The 
determined kcat and Km values revealed a 2KIE (Table 4.2) on both Vmax (2Vmax = 






Figure 4.17: Briggs-Haldane fit (R2 = 0.99) for the kinetics of TruB with TSL 






Figure 4.18: Briggs-Haldane fit (R2 = 0.98) for the kinetics of RluA with ASL 








 Vmax, nM/s Km, µM 2Vmax 2(Vmax/Km) 
TruB  
unlabeled TSL 3.373 ± 0.178 1.334 ± 0.318 
2.54 ± 0.14 3.58 ± 0.27 
labeled TSL 1.223 ± 0.020 1.733 ± 0.116 
RluA  
unlabeled ASL 13.938 ± 0.840 1.318 ± 0.412 
1.79 ± 0.09 2.17 ± 0.09 
labeled ASL 7.773 ± 0.745 1.594 ± 0.691 
Table 4.2: Kinetic parameters for TruB and RluA with substrates 




To obtain definitive evidence for glycal intermediate formation during the 
conversion of U to Ψ, 2KIE were measured. TSL and ASL were prepared by 
synthesizing [2′-2H]UTP and incorporating it into RNA by in vitro transcription.  
Subcloning, overexpression and purification  
The overexpression of PRPP synthetase and UPRTase posed no 
problems. The specific activities of the purified enzymes were similar to literature 
values (Table 4.1). [95] However, the plasmid encoding ribokinase (pET-22HT) 
[91] afforded poor levels of overexpression of barely active enzyme (Table 4.1). 
DNA sequencing revealed an overhang after the stop codon and an inverted 
duplication towards the 5′-end. These errors were rectified by introducing NdeI and 
BamHI restriction sites on to the immediate 5′- and 3′-ends of rbsK to allow the 
precise placement of rbsK into pET-15b to overexpress ribokinase with an N-
terminal His6•tag. The specific activity of the ribokinase thus obtained mildly 
exceeded the published value (Table 4.1). [95]  
With the enzymes in hand, [2′-2H]UTP was synthesized enzymatically 
(Figure 4.9). The synthesis requires at least 4 equivalents of ATP per equivalent 
of [2′-2H]UTP being formed, but high concentrations of ATP could not be directly 
used in the synthesis because released ADP would inhibit ribokinase and PRPP 
synthetase. These issues were addressed by in situ regeneration of ATP at the 
expense of PEP using pyruvate kinase and myokinase. The use of excess PEP 
drove [2′-2H]UTP synthesis to completion. However, the separation of the 
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synthesized [2′-2H]UTP from residual PEP and the by-product pyruvate presented 
a challenge. Charcoal adsorption proved a simple but effective means to separate 
[2′-2H]UTP from PEP and pyruvate. Finally, [2′-2H]UTP was separated from ATP 
by solid phase extraction over a C8 matrix. 
In vitro transcription 
Run-off transcription with T7 RNA polymerase is a convenient route to short 
oligonucleotides. [99, 102] The DNA sequence complementary to the required 
RNA product is placed downstream of the T7 promoter, which must be double-
stranded for T7 RNA polymerase to bind. Efficient transcription requires G as the 
first transcribed nucleotide (the +1 position). For the in vitro transcription of TSL 
(Figure 4.13, panel A), an extra G was introduced on to the 5′-end for this purpose 
because the canonical TSL used in earlier studies of TruB [29, 52] starts with a C.7 
The canonical ASL used previously [30] begins with a run of four Gs, which 
sometimes causes the polymerase to “slip” back by one nucleotide, resulting in a 
“ladder” of transcripts. This phenomenon was apparent during the transcription of 
canonical ASL (Figure 4.14, panel A). Therefore, ASL was modified (Figure 4.14, 
panel B) by reversing the second base pair in the stem loop, which resulted in the 
sequence: 5′-GCGGAUUGAAAAUCCGC-3′ (underlined regions represent the 
swapped nucleotides of the stem loop; Figure 4.13, panel B). 
The concentration of rNTPs, template DNA, T7 RNA polymerase, and the 
length of the reaction incubation play an important role in obtaining good yields of 
                                                
7 It is the T-arm of S. cerevisiae tRNAPhe and prepared by chemical synthesis rather than 
the in vitro transcription. 
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transcripts. The slow step in transcription is initiation, which is directly affected by 
the concentration of rNTPs and T7 RNA polymerase. T7 RNA polymerase also 
tends to produce abortive transcripts 3-12 nucleotides in length before switching 
into its hardier processive mode, so there is a chance for the depletion of the rNTPs 
of nucleotides abundant in the initial part of the transcript. [99, 102] In the 
transcription of oligonucleotides shorter than 20-mers, a higher concentration of 
DNA template (0.5-1 µM) and T7 RNA polymerase (2500 U/ml) yield better results 
[99, 102] because of the increase in the number of transcription initiation events. 
All of these considerations went into the optimization of conditions to maximize the 
yield of transcript with precious [2′-2H]UTP. The optimized conditions yielded 
sufficient TSL and ASL (both labeled and unlabeled) for the kinetic studies, and 
the sequence of the purified transcripts were verified by digestion with RNase T1 
and analysis by MALDI-TOF mass spectrometry. 
Deuterium kinetic isotope effect studies 
A deuterium kinetic isotope effect (2KIE) is the observed change in rate of a 
chemical reaction when one of the protons in the reactants is substituted with a 
(heavier) deuteron. Kinetic isotope effects arise from differences in zero-point 
energy levels for the isotopologues of interest in the ground and transition states 
(Figure 4.19). [88, 103] In the case of “a proton in flight” (a primary KIE), there is 
no zero-point energy difference at the transition state for proton transfer, so the 
lower zero-point energy level of deuterium versus protium translates in to a larger 
activation energy barrier for the heavier isotope and hence a decreased reaction 
rate. In this classical analysis, the zero point energy difference between protium 
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and deuterium dictates a maximum value of 6.9 for a primary 2KIE, [88] but larger 
effects are seen when tunneling is involved because of the substantially short de 
Broglie wavelength of a deuteron (0.45 Å) versus a proton (0.63 Å). [88] A 
secondary effect arises when the deuterium remains bonded throughout the 
reaction to a carbon atom that undergoes a change in hybridization. The 
differences in the energy of bond bending modes between sp2 and sp3 centers 
impose a maximum theoretical value of 1.4 for a secondary 2KIE. [88] 
For TruB with unlabeled TSL, kcat = 0.337 ± 0.025 s-1 and Km = 1.334 ± 
0.318 µM, values in agreement with those reported previously (kcat = 0.24 s-1, Km 
= 0.8 µM). [29] These observations suggest that the in vitro transcribed TSL serves 
as an excellent substrate for TruB despite the addition of an unpaired 5′-G. The 
observed 2KIE on Vmax (2.54) and Vmax/Km (3.58) indicate that deprotonation or 
reprotonation of C2′ (or both) is partially rate limiting and provide direct evidence 
for the operation of glycal mechanism (Figure 4.3) during the conversion of U 
to Ψ.  
RluA was chosen to test the generality of this finding with another family of 
Ψ synthases. The kcat (0.558 ± 0.010 s-1) and Km (1.32 ± 0.42 µM) with the in vitro 
transcribed ASL with a reversed base pair in the stem were some 8–fold higher 
than those previously reported (kcat = 0.067 ± 0.003 s-1, Km = 308 ± 66 nM) with 
canonical ASL, [30] indicating that this “new” ASL is an efficient substrate. Primary 
2KIEs were observed for Vmax (1.79) and Vmax/Km (2.17), again indicative of the 
operation of the glycal mechanism. These results with RluA cemented the 
observations with TruB, thereby providing unambiguous evidence for a glycal 
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intermediate in the operation of two Ψ synthase families and thus, by implication, 






Figure 4.19: The primary 2KIE. Zero-point energy differences for a C-H 
bond compared to that of a C-D bond. Picture taken from reference 103. 
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time, sec Ψ U Ψ+U G A C 
1 µM TSL 
0 0 5.00 5.0 5.4 3.0 5.0 
30 0.064 4.94 5.00 5.4 3.0 5.0 
60 0.119 4.90 5.02 5.5 3.0 5.0 
90 0.157 4.84 5.00 5.5 3.0 5.0 
120 0.206 4.77 4.98 5.5 3.0 5.0 
5 µM TSL 
60 0.046 4.96 5.01 5.5 3.0 5.0 
90 0.061 4.94 5.00 5.5 3.0 5.0 
120 0.076 4.92 5.00 5.5 3.0 5.0 
150 0.091 4.91 5.00 5.5 3.0 5.0 
8 µM TSL 
60 0.021 4.99 5.01 5.4 3.0 5.0 
120 0.049 4.92 4.97 5.5 3.0 5.0 
240 0.091 4.9 4.99 5.5 3.0 5.0 
360 0.106 4.9 5.01 5.5 3.0 5.0 
10 µM TSL 
60 0.017 4.99 5.01 5.5 3.0 5.0 
120 0.035 4.95 4.99 5.4 3.0 5.0 
240 0.071 4.93 5.00 5.5 3.0 5.0 
300 0.09 4.89 4.98 5.5 3.0 5.0 





Table 4.3: The quantitation of nucleoside peaks from the HPLC traces for 
kinetic assays of TruB with unlabeled TSL. Relative integrations were 
adjusted with ε260 for each nucleotide and normalized by assuming a value 




time, sec Ψ U Ψ+U G A C 
1 µM TSL 
0 0 5.00 5.0 5.4 3.0 5.0 
60 0.072 4.88 4.95 5.4 3.0 5.0 
120 0.100 4.91 5.01 5.5 3.0 5.0 
180 0.135 4.85 4.99 5.5 3.1 5.0 
240 0.152 4.85 5.00 5.4 3.0 5.0 
5 µM TSL 
60 0.014 4.99 5.00 5.4 3.0 5.0 
120 0.024 4.98 5.00 5.4 3.0 5.0 
240 0.044 4.94 4.98 5.4 3.0 5.0 
300 0.061 4.95 5.01 5.3 3.0 5.0 
8 µM TSL 
120 0.029 4.99 5.02 5.4 3.0 5.0 
180 0.043 4.97 5.01 5.4 3.0 5.0 
240 0.049 4.94 4.99 5.4 3.0 5.0 
360 0.063 4.94 5.00 5.4 3.0 5.0 
10 µM TSL 
120 0.032 4.97 5.00 5.5 3.0 5.0 
180 0.037 4.97 5.01 5.5 3.0 5.0 
240 0.046 4.95 5.00 5.5 3.0 5.0 
360 0.054 4.92 4.97 5.4 3.0 5.0 
120 0.032 4.97 5.00 5.5 3.0 5.0 
Table 4.4: The quantitation of nucleoside peaks from the HPLC traces for 
kinetic assays of TruB with labeled TSL. Relative integrations were 
adjusted with ε260 for each nucleotide and normalized by assuming a value 




time, sec Ψ U Ψ+U G A C 
2.5 µM ASL 
0 0 3.0 3.0 5.4 5.0 4.0 
25 0.206 2.79 3.00 5.4 5.0 4.0 
45 0.275 2.73 3.01 5.5 4.9 4.0 
65 0.332 2.66 2.99 5.4 5.1 4.0 
85 0.405 2.49 2.90 5.4 5.1 4.0 
5 µM ASL 
25 0.138 2.86 3.00 5.5 5.1 4.0 
47 0.200 2.80 3.00 5.4 5.0 4.0 
66 0.239 2.76 3.00 5.4 5.0 4.0 
85 0.264 2.74 3.00 5.4 5.0 4.0 
6.5 µM ASL 
24 0.029 2.98 3.01 5.4 5.0 4.0 
41 0.043 2.97 3.01 5.5 4.9 4.0 
58 0.049 2.94 2.99 5.5 5.0 4.0 
80 0.063 2.94 3.00 5.5 5.0 4.0 
8 µM ASL 
23 0.112 2.89 3.00 5.4 5.0 4.0 
40 0.170 2.84 3.01 5.4 5.1 4.0 
60 0.238 2.81 3.05 5.4 4.9 4.0 
80 0.245 2.85 3.10 5.4 5.1 4.0 
23 0.112 2.89 3.00 5.4 5.0 4.0 
10 µM ASL 
28 0.109 2.9 3.01 5.4 5.0 4.0 
48 0.136 2.87 3.01 5.4 5.0 4.0 
66 0.166 2.84 3.01 5.4 5.1 4.0 
85 0.208 2.8 3.01 5.4 5.0 4.0 
28 0.109 2.9 3.01 5.4 5.0 4.0 
  
Table 4.5: The quantitation of nucleoside peaks from the HPLC traces for 
kinetic assays of RluA with unlabeled ASL. Relative integrations were 
adjusted with ε260 for each nucleotide and normalized by assuming a value 
of 4.0 for C. 
179 
 
time, sec Ψ U Ψ+U G A C 
2.5 µM ASL 
0 0 3.0 3.0 5.4 5.0 4.0 
24 0.167 2.83 3.00 5.4 5.0 4.0 
40 0.192 2.81 3.00 5.4 5.0 4.0 
55 0.218 2.78 3.00 5.5 5.0 4.0 
78 0.261 2.74 3.00 5.4 5.1 4.0 
5 µM ASL 
25 0.130 2.87 3.00 5.4 5.0 4.0 
44 0.153 2.85 3.00 5.4 4.0 4.0 
63 0.186 2.82 3.01 5.4 5.0 4.0 
85 0.211 2.79 3.00 5.4 5.0 4.0 
6.5 µM ASL 
19 0.100 2.90 3.00 5.4 5.0 4.0 
35 0.109 2.89 3.00 5.5 5.0 4.0 
50 0.128 2.87 3.00 5.4 5.0 4.0 
70 0.152 2.85 3.00 5.4 5.1 4.0 
8 µM ASL 
23 0.076 2.92 3.00 5.5 5.0 4.0 
40 0.079 2.92 3.00 5.5 5.0 4.0 
60 0.090 2.91 3.00 5.5 5.0 4.0 
80 0.105 2.89 3.00 5.4 5.0 4.0 
23 0.076 2.92 3.00 5.5 5.0 4.0 
10 µM ASL 
25 0.126 2.88 3.01 5.4 4.9 4.0 
43 0.137 2.86 3.00 5.4 5.0 4.0 
63 0.153 2.85 3.00 5.4 5.0 4.0 
83 0.161 2.84 3.00 5.4 4.9 4.0 
25 0.126 2.88 3.01 5.4 4.9 4.0 
  
Table 4.6: The quantitation of nucleoside peaks from the HPLC traces for 
kinetic assays of RluA with labeled ASL. Relative integrations were 
adjusted with ε260 for each nucleotide and normalized by assuming a value 




Three different mechanisms have been proposed for Ψ synthases, and they 
all involve the conserved Asp acting as either a nucleophile or a base. [36, 43] In 
the ‘Michael mechanism’ (Figure 4.1), the conserved Asp acts as a nucleophile to 
attack C6 of the pyrimidine ring to form a Michael adduct. This mechanism was 
based on findings with TruA, which upon incubation with [F5U]RNA gets 
irreversibly inhibited and appears in an adduct band on denaturing PAGE gels.[36] 
The ‘acylal’ mechanism (Figure 4.2) instead proposes a nucleophilic attack at the 
C1′ of the ribose ring by the conserved Asp. Studies with TruB provided more 
mechanistic clues into the action of Ψ synthases. Whereas TruA and RluA form 
adducts when incubated with [F5U]RNA, TruB does not, nor does it get inhibited 
by [F5U]RNA but instead converts F5U into two rearranged and hydrated products 
that differ in stereochemistry at C2′. [25, 43]  
18O labeling studies with TruA, TruB, RluA, TruD and TmTruB [30, 41, 42, 
67] all show that the hydration of the products of F5U occurs directly from solution 
and not through the hydrolysis of a Michael adduct. A consistent scheme was then 
proposed by Mueller and co-workers for the hydration of F5U, and it has been 
slightly revised to accommodate the arabino product of F5U (Figure 2.23). By any 
mechanism, the Ψ synthases rearrange F5U, and idiosyncracies of the active site 
dictate its fate. In some active sites (TruA and RluA), the conserved Asp or some 
other nucleophile in the active site can reach C6 to make a stable adduct. The 
adduct, upon heating, undergoes elimination (rather than ester hydrolysis), 
followed by the spontaneous hydration of the rearranged F5U in solution. [30, 41] 
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In other active sites (TruB, for example), the conserved Asp does not form a stable 
adduct with the pyrimidine, so the rearranged F5U is simply released into solution 
followed by hydration. This proposed scheme for hydration is consistent with 
TmTruB, which reversibly forms an adduct when incubated with [F5U]RNA: after 
rearrangement, the C-glycoside of F5U either gets trapped (whether by the 
conserved Asp or some other active site residue) or gets released into solution, 
where it becomes hydrated. The cocrystal structure of RluB with [F5U]RNA [46] 
shows a covalent bond between the hydroxyl group of Tyr-146 and the pyrimidine 
ring of F5U, which is also consistent with the scheme that proposes the trapping of 
the rearranged F5U. 
Structural elucidation of the products of F5U by Miracco and Mueller [43] 
revealed that the major (ribo) and minor (arabino) products of F5U differ in their 
stereochemistry at C2′, which requires epimerization through the formation of a 
glycal intermediate. Either the conserved Asp or O2 of the pyrimidine ring can 
deprotonate C2′ to form the glycal intermediate, and reprotonation of C2′ from the 
“bottom” face yields the arabino product of F5U. The existence of the arabino 
product strongly disfavors the Michael mechanism because the conserved Asp is 
tied up in an ester bond during the crucial deprotonation/reprotonation of C2′. If O2 
instead deprotonates the C2′ by acting as a base, [87] the Michael mechanism 
may still be valid if solvent reprotonates C2′. However, the lack of deuterium wash-
in for TruB and RluA with RNA containing U and F5U discredits this hypothesis. 
[67] These results also favor the conserved Asp as the base for the deprotonation 
step because it gets the conserved Asp into its acid form to reprotonate C2′ from 
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the ‘bottom’ face. A variation of the Michael mechanism that can account for the 
arabino product would be the formation of the Michael adduct by the active site 
tyrosine residue, which would result in the conserved Asp remaining free to 
deprotonate and reprotonate C2′. The Ψ synthases share a conserved aromatic 
amino acid residue, which is a tyrosine in five of the six families (this Tyr-146 
residue is adducted with [F5U]RNA in the RluB cocrystal). However, this 
hypothesis can also be discredited for several reasons. The fully functional TruD 
family has non-nucleophilic phenylalanine residues in this conserved position. [48-
50] Huang and co-workers found that substitution of this tyrosine residue in TruB 
with phenylalanine, leucine, or alanine resulted in an enzyme that can no longer 
handle the natural substrate (with U) but can handle [F5U]RNA to rearrange and 
hydrate F5U. [51] If the tyrosine residue forms the initial Michael adduct, these 
variants should have left both U and F5U unchanged (if the adduct does not form, 
no rearrangement to the C-glycoside should occur). Finally, the pH profile of TruB 
suggests that the active site tyrosine residue functions in its protonated form and 
thus is better suited to assist the N-glycosidic bond cleavage of the uridine, by 
donating either a proton or hydrogen bond to the pyrimidine ring. [26, 52] Cleavage 
of F5U at the N-glycosidic bond does not require the assisting tyrosine residue 
because the inductive effect of fluorine creates a better leaving group than with 
uridine. 
The arabino product of F5U can be explained as part of the acylal 
mechanism (Figure 3.2). The decreased nucleophilicity of the fluorouracilate anion 
provides a longer lifetime for the acylal and oxocarbenium intermediates, thereby 
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allowing them to access an alternate reaction pathway. The increased acidity of 
C2′ in the oxocarbenium allows its deprotonation by the conserved Asp to form a 
glycal intermediate. Reprotonation of C2′ from the “bottom” face would then result 
in the arabino product of F5U.  
The existence of a glycal intermediate along the reaction pathway of F5U 
opens up a new mechanistic possibility, the ‘glycal’ mechanism (Figure 4.3) in 
which the glycal intermediate forms during the conversion of U to Ψ. The low levels 
of deuterium wash-in observed in the F5U products with both wild-type and Y76L 
TruB (undetectable and <4.5%, respectively) indicate that the conserved Asp is 
sequestered from solvent on the time scale of conversion of F5U to its products 
and are consistent with a glycal intermediate along the F5U reaction pathway 
(whether it is the acylal mechanism, or glycal mechanism that operates).  
The observed primary 2KIE with TruB and RluA for U to Ψ unambiguously 
indicates the operation of the glycal mechanism for these two Ψ synthases from 
different families. The active sites of all six families have several conserved 
residues along with the absolutely conserved Asp that is essential for activity, [9, 
10, 24-27] which strongly suggests that they all operate through a single 
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